Novel Fatty Acid Desaturases And Elongases And Uses Thereof (Patent WO 2011/006948 A1) by Bauer, J. et al.
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT)
(19) World Intellectual Property Organization
International Bureau
(10) International Publication Number(43) International Publication Date
20 January 2011 (20.01.2011) WO 2011/006948 Al
(51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ,
C07K 14/435 (2006.01) C12N 15/82 (2006.01) CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO,
DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT,(21) International Application Number: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP,
PCT/EP20 10/060 178 KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD,
(22) International Filing Date: ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI,
15 July 2010 (15.07.2010) NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD,
SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR,
(25) Filing Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
(26) Publication Language: English (84) Designated States (unless otherwise indicated, for every
(30) Priority Data: kind of regional protection available): ARIPO (BW, GH,
61/226,301 17 July 2009 (17.07.2009) US GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG,
09165752.8 17 July 2009 (17.07.2009) EP ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ,
TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK,
(71) Applicant (for all designated States except US): BASF EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU,
PLANT SCIENCE COMPANY GMBH [DE/DE]; LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK,
67056 Ludwigshafen (DE). SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ,
GW, ML, MR, NE, SN, TD, TG).(72) Inventors; and
(75) Inventors/Applicants (for US only): BAUER, Jorg [DE/ Published:
DE]; Gluckstr. Ib, 145 13 Teltow (DE). NAPIER,
— with international search report (Art. 21(3))Johnathan, A. [GB/GB]; The Wilderness, Butchers Lane,
Preston, Hertfordshire SG4 7TR (GB). SAYANOVA, — before the expiration of the time limit for amending the
Olga [GB/GB]; 43 Snatchup, Redbourn, St. Albans AL3 claims and to be republished in the event of receipt of
7HF (GB). amendments (Rule 48.2(h))
(74) Agent: POPP, Andreas; 67056 Ludwigshafen (DE). — with sequence listing part of description (Rule 5.2(a))
(81) Designated States (unless otherwise indicated, for every
kind of national protection available): AE, AG, AL, AM,
(54) Title: NOVEL FATTY ACID DESATURASES AND ELONGASES AND USES THEREOF
(57) Abstract: The invention provides isolated nucleic acid molecules which encode novel fatty acid desaturases and elongases
from the organism Emiliana huxleyi. The invention also provides recombinant expression vectors containing desaturase or elon-
gase nucleic acid molecules, host cells into which the expression vectors have been introduced, and methods for large-scale pro-
duction of long chain polyunsaturated fatty acids (LCPUFAs), e.g. arachidonic acid (ARA), eicosapentaenoic acid (EPA) or do-
cosahexaenoic acid (DHA).
NOVEL FATTY ACID DESATURASES AND ELONGASES AND USES THEREOF
The invention in principle pertains to the field of recombinant manufacture of fatty acids. It
provides nucleic acid molecules which encode novel fatty acid desaturases and elongases.
The invention also provides recombinant expression vectors containing desaturase and
elongase nucleic acid molecules, host cells into which the expression vectors have been
introduced, and methods for large-scale production of long chain polyunsaturated fatty
acids (LCPUFAs), e.g. arachidonic acid (ARA), eicosapentaenoic acid (EPA) or
docosahexaenoic acid (DHA).
Fatty acids are carboxylic acids with long-chain hydrocarbon side groups that play a
fundamental role in many biological processes. Fatty acids are rarely found free in nature
but, rather, occur in esterified form as the major component of lipids. As such, lipids/ fatty
acids are sources of energy (e.g., b-oxidation). In addition, lipids/ fatty acids are an integral
part of cell membranes and, therefore, are indispensable for processing biological or
biochemical information.
Fatty acids can be divided into two groups: saturated fatty acids formed of single carbon
bonds and the unsaturated fatty acids which contain one or more carbon double bonds in
cis-configuration. Unsaturated fatty acids are produced by terminal desaturases that belong
to the class of nonheme-iron enzymes. Each of these enzymes are part of an electron-
transport system that contains two other proteins, namely cytochrome b and NADH-
cytochrome b reductase. Specifically, such enzymes catalyze the formation of double
bonds between the carbon atoms of a fatty acid molecule, for example, by catalyzing the
oxygen-dependent dehydrogenation of fatty acids (Sperling et al., 2003). Human and other
mammals have a limited spectrum of desaturases that are required for the formation of
particular double bonds in unsaturated fatty acids and thus, have a limited capacity for
synthesizing essential fatty acids, e.g., long chain polyunsaturated fatty acids (LCPUFAs).
Thus, humans have to take up some fatty acids through their diet. Such essential fatty acids
include, for example, linoleic acid (C18:2), linolenic acid (C18:3). In contrast, insects,
microorganisms and plants are able to synthesize a much larger variety of unsaturated fatty
acids and their derivatives. Indeed, the biosynthesis of fatty acids is a major activity of
plants and microorganisms.
Long chain polyunsaturated fatty acids (LCPUFAs) such as docosahexaenoic acid (DHA,
22:6(4,7,10,13,16,19)) are essential components of cell membranes of various tissues and
organelles in mammals (nerve, retina, brain and immune cells). For example, over 30% of
fatty acids in brain phospholipid are 22:6 (n-3) and 20:4 (n-6) (Crawford, M.A., et al., (1997)
Am. J. Clin. Nutr. 66:1032S-1041S). In retina, DHA accounts for more than 60% of the total
fatty acids in the rod outer segment, the photosensitive part of the photoreceptor cell
(Giusto, N.M., et al. (2000) Prog. Lipid Res. 39:315-391). Clinical studies have shown that
DHA is essential for the growth and development of the brain in infants, and for
maintenance of normal brain function in adults (Martinetz, M. (1992) J . Pediatr.
120:S129-S138). DHA also has significant effects on photoreceptor function involved in the
signal transduction process, rhodopsin activation, and rod and cone development (Giusto,
N.M., et al. (2000) Prog. Lipid Res. 39:315-391). In addition, some positive effects of DHA
were also found on diseases such as hypertension, arthritis, atherosclerosis, depression,
thrombosis and cancers (Horrocks, L.A. and Yeo, Y .K . (1999) Pharmacol. Res.
40:21 1-215). Therefore, appropriate dietary supply of the fatty acid is important for human
health. Because such fatty acids cannot be efficiently synthesized by infants, young children
and senior citizerns, it is particularly important for these individuals to adequately intake
these fatty acids from the diet (Spector, A.A. (1999) Lipids 34:S1-S3).
Currently the major sources of DHA are oils from fish and algae. Fish oil is a major and
traditional source for this fatty acid, however, it is usually oxidized by the time it is sold. In
addition, the supply of fish oil is highly variable, particularly in view of the shrinking fish
populations. Moreover, the algal source of oil is expensive due to low yield and the high
costs of extraction.
EPA and ARA are both ∆5 essential fatty acids. They form a unique class of food and feed
constituents for humans and animals. EPA belongs to the n-3 series with five double bonds
in the acyl chain. EPA is found in marine food and is abundant in oily fish from North
Atlantic. ARA belongs to the n-6 series with four double bonds. The lack of a double bond in
the co-3 position confers on ARA different properties than those found in EPA. The
eicosanoids produced from AA have strong inflammatory and platelet aggregating
properties, whereas those derived from EPA have anti-inflammatory and anti-platelet
aggregating properties. ARA can be obtained from some foods such as meat, fish and
eggs, but the concentration is low.
Gamma-linolenic acid (GLA) is another essential fatty acid found in mammals. GLA is the
metabolic intermediate for very long chain n-6 fatty acids and for various active molecules.
In mammals, formation of long chain polyunsaturated fatty acids is rate-limited by ∆6
desaturation. Many physiological and pathological conditions such as aging, stress,
diabetes, eczema, and some infections have been shown to depress the ∆6 desaturation
step. In addition, GLA is readily catabolized from the oxidation and rapid cell division
associated with certain disorders, e.g., cancer or inflammation. Therefore, dietary
supplementation with GLA can reduce the risks of these disorders. Clinical studies have
shown that dietary supplementation with GLA is effective in treating some pathological
conditions such as atopic eczema, premenstrual syndrome, diabetes, hypercholesterolemia,
and inflammatory and cardiovascular disorders.
A large number of benefitial health effects have been shown for DHA or mixtures of
EPA/DHA. DHA is a n-3 very long chain fatty acid with six double bonds.
Although biotechnology offers an attractive route for the production of specialty fatty acids,
current techniques fail to provide an efficient means for the large scale production of
unsaturated fatty acids. Accordingly, there exists a need for an improved and efficient
method of producing unsaturated fatty acids, such as DHA, EPA and ARA.
Thus, the present invention relates to a polynucleotide comprising a nucleic acid sequence
elected from the group consisting of:
a) a nucleic acid sequence having a nucleotide sequence as shown in SEQ ID NOs: 1, 3 ,
5 , 7 or 9 ;
b) a nucleic acid sequence encoding a polypeptide having an amino acid sequence as
shown in SEQ ID NOs: 2 , 4 , 6 , 8 or 10;
c) a nucleic acid sequence being at least 70% identical to the nucleic acid sequence of
a) or b), wherein said nucleic acid sequence encodes a polypeptide having
desaturase or elongase activity;
d) a nucleic acid sequence encoding a polypeptide having desaturase or elongase
activity and having an amino acid sequence which is at least 82% identical to the
amino acid sequence of any one of a) to c); and
e) a nucleic acid sequence which is capable of hybridizing under stringent conditions to
any one of a) to d), wherein said nucleic acid sequence encodes a polypeptide having
desaturase or elongase activity.
The term " polynucleotide" as used in accordance with the present invention relates to a
polynucleotide comprising a nucleic acid sequence which encodes a polypeptide having
desaturase or elongase activity. Preferably, the polypeptide encoded by the polynucleotide
of the present invention having desaturase or elongase activity upon expression in a plant
shall be capable of increasing the amount of PUFA and, in particular, LCPUFA in, e.g.,
seed oils or the entire plant or parts thereof. Such an increase is, preferably, statistically
significant when compared to a LCPUFA producing transgenic control plant which
expresses the the present state of the art set of desaturases and elongases requiered for
LCPUFA synthesis but does not express the polynucleotide of the present invention.
Whether an increase is significant can be determined by statistical tests well known in the
art including, e.g., Student 's t-test. More preferably, the increase is an increase of the
amount of triglycerides containing LCPUFA of at least 5%, at least 10%, at least 15%, at
least 20% or at least 30% compared to the said control. Preferably, the LCPUFA referred to
before is a polyunsaturated fatty acid having a C-20 or C-22 fatty acid body, more
preferably, ARA, EPA or DHA. Suitable assays for measuring the activities mentioned
before are described in the accompanying Examples.
The term " desaturase" or " elongase" as used herein refers to the activity of a
desaturase, introducing a double bond into the carbon chain of a fatty acid, preferably into
fatty acids with 18 , 20 or 22 carbon molecules, or an elongase, introducing two carbon
molecules into the carbon chain of a fatty acid, preferably into fatty acids with 18, 20 or 22
carbon molecules
More preferably, polynucleotides having a nucleic acid sequence as shown in SEQ ID NOs:
1, 3 , 5 , 7 or 9 encoding polypeptides having amino acid sequences as shown in SEQ ID
NOs: 2 , 4 , 6 , 8 or 10 or variants thereof, preferably, exhibit desaturase or elongase activity.
Polynucleotides encoding a polypeptide having desaturase or elongase activity as specified
above has been obtained in accordance with the present invention, preferably, from
Emiliana huxleyi. However, orthologs, paralogs or other homologs may be identified from
other species. Preferably, they are obtained from plants such as algae, for example
Isochrysis, Mantoniella, Ostreococcus or Crypthecodinium, algae/diatoms such as
Phaeodactylum, Thalassiosira or Thraustochytrium, mosses such as Physcomitrella or
Ceratodon, or higher plants such as the Primulaceae such as Aleuritia, Calendula stellata,
Osteospermum spinescens or Osteospermum hyoseroides, microorganisms such as fungi,
such as Aspergillus, Phytophthora, Entomophthora, Mucor or Mortierella, bacteria such as
Shewanella, yeasts or animals. Preferred animals are nematodes such as Caenorhabditis,
insects or vertebrates. Among the vertebrates, the nucleic acid molecules may, preferably,
be derived from Euteleostomi, Actinopterygii; Neopterygii; Teleostei; Euteleostei,
Protacanthopterygii, Salmoniformes; Salmonidae or Oncorhynchus, more preferably, from
the order of the Salmoniformes, most preferably, the family of the Salmonidae, such as the
genus Salmo, for example from the genera and species Oncorhynchus mykiss, Trutta trutta
or Salmo trutta fario. Moreover, the nucleic acid molecules may be obtained from the
diatoms such as the genera Thallasiosira or Phaeodactylum.
Thus, the term " polynucleotide" as used in accordance with the present invention further
encompasses variants of the aforementioned specific polynucleotides representing
orthologs, paralogs or other homologs of the polynucleotide of the present invention.
Moreover, variants of the polynucleotide of the present invention also include artificially
generated muteins. Said muteins include, e.g., enzymes which are generated by
mutagenesis techniques and which exhibit improved or altered substrate specificity, or
codon optimized polynucleotides. The polynucleotide variants, preferably, comprise a
nucleic acid sequence characterized in that the sequence can be derived from the
aforementioned specific nucleic acid sequences shown in any one of SEQ ID NOs: 1, 3 , 5 ,
7 or 9 or by a polynucleotide encoding a polypeptide having an amino acid sequence as
shown in any one of SEQ ID NOs: 2 , 4 , 6 , 8 or 10 by at least one nucleotide substitution,
addition and/or deletion, whereby the variant nucleic acid sequence shall still encode a
polypeptide having a desaturase or elongase activity as specified above. Variants also
encompass polynucleotides comprising a nucleic acid sequence which is capable of
hybridizing to the aforementioned specific nucleic acid sequences, preferably, under
stringent hybridization conditions. These stringent conditions are known to the skilled
worker and can be found in Current Protocols in Molecular Biology, John Wiley & Sons, N .
Y. (1989), 6.3.1-6.3.6. A preferred example for stringent hybridization conditions are
hybridization conditions in 6 x sodium chloride/sodium citrate (= SSC) at approximately
450C, followed by one or more wash steps in 0.2 x SSC, 0.1 % SDS at 50 to 650C. The
skilled worker knows that these hybridization conditions differ depending on the type of
nucleic acid and, for example when organic solvents are present, with regard to the
temperature and concentration of the buffer. For example, under " standard hybridization
conditions" the temperature differs depending on the type of nucleic acid between 42°C
and 580C in aqueous buffer with a concentration of 0.1 to 5 x SSC (pH 7.2). If organic
solvent is present in the abovementioned buffer, for example 50% formamide, the
temperature under standard conditions is approximately 420C. The hybridization conditions
for DNA: DNA hybrids are, preferably, 0.1 x SSC and 2 O0C to 45°C, preferably between
3 O0C and 450C. The hybridization conditions for DNA:RNA hybrids are, preferably, 0.1 x
SSC and 3 O0C to 550C, preferably between 45°C and 550C. The abovementioned
hybridization temperatures are determined for example for a nucleic acid with approximately
100 bp (= base pairs) in length and a G + C content of 50% in the absence of formamide.
The skilled worker knows how to determine the hybridization conditions required by
referring to textbooks such as the textbook mentioned above, or the following textbooks:
Sambrook et al., "Molecular Cloning" , Cold Spring Harbor Laboratory, 1989; Hames and
Higgins (Ed.) 1985, " Nucleic Acids Hybridization: A Practical Approach" , IRL Press at
Oxford University Press, Oxford; Brown (Ed.) 1991 , "Essential Molecular Biology: A
Practical Approach" , IRL Press at Oxford University Press, Oxford. Alternatively,
polynucleotide variants are obtainable by PCR-based techniques such as mixed
oligonucleotide primer- based amplification of DNA, i.e. using degenerated primers against
conserved domains of the polypeptides of the present invention. Conserved domains of the
polypeptide of the present invention may be identified by a sequence comparison of the
nucleic acid sequences of the polynucleotides or the amino acid sequences of the
polypeptides of the present invention. Oligonucleotides suitable as PCR primers as well as
suitable PCR conditions are described in the accompanying Examples. As a template, DNA
or cDNA from bacteria, fungi, plants or animals may be used. Further, variants include
polynucleotides comprising nucleic acid sequences which are at least 50%, at least 55%, at
least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least
90%, at least 95%, at least 98% or at least 99% identical to the nucleic acid sequences
shown in any one of SEQ ID NOs: 1, 3 , 5 , 7 or 9 , preferably, encoding polypeptides
retaining a desaturase or elongase activity as specified above. Moreover, also
encompassed are polynucleotides which comprise nucleic acid sequences encoding a
polypeptide having an amino acid sequences which are at least 50%, at least 55%, at least
60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at
least 95%, at least 98% or at least 99% identical to the amino acid sequences shown in any
one of SEQ ID NOs: 2 , 4 , 6 , 8 or 10, wherein the polypeptide, preferably, retains desaturase
or elongase activity as specified above. The percent identity values are, preferably,
calculated over the entire amino acid or nucleic acid sequence region. A series of programs
based on a variety of algorithms is available to the skilled worker for comparing different
sequences. In a preferred embodiment, the percent identity between two amino acid
sequences is determined using the Needleman and Wunsch algorithm (Needleman 1970, J.
MoI. Biol. (48):444-453) which has been incorporated into the needle program in the
EMBOSS software package (EMBOSS: The European Molecular Biology Open Software
Suite, Rice,P., Longden,!., and Bleasby,A, Trends in Genetics 16(6), 276-277, 2000), using
either a BLOSUM 45 or PAM250 scoring matrix for distantly related proteins, or either a
BLOSUM 62 or PAM160 scoring matrix for closer related proteins, and a gap opening
penalty of 16, 14, 12, 10, 8 , 6, or 4 and a gap entension pentalty of 0.5, 1, 2 , 3 , 4 , 5 , or 6 .
Guides for local installation of the EMBOSS package as well as links to WEB-Services can
be found at http://emboss.sourceforge.net. A preferred, non-limiting example of parameters
to be used for aligning two amino acid sequences using the needle program are the default
parameters, including the EBLOSUM62 scoring matrix, a gap opening penalty of 10 and a
gap extension penalty of 0.5. In yet another preferred embodiment, the percent identity
between two nucleotide sequences is determined using the needle program in the
EMBOSS software package (EMBOSS: The European Molecular Biology Open Software
Suite, Rice,P., Longden,!., and Bleasby,A, Trends in Genetics 16(6), 276-277, 2000), using
the EDNAFULL scoring matrix and a gap opening penalty of 16, 14, 12, 10, 8 , 6 , or 4 and a
gap extension penalty of 0.5,1 , 2 , 3 , 4 , 5 , or 6 . A preferred, non-limiting example of
parameters to be used in conjunction for aligning two amino acid sequences using the
needle program are the default parameters, including the EDNAFULL scoring matrix, a gap
opening penalty of 10 and a gap extension penalty of 0.5. The nucleic acid and protein
sequences of the present invention can further be used as a " query sequence" to
perform a search against public databases to, for example, identify other family members or
related sequences. Such searches can be performed using the BLAST series of programs
(version 2.2) of Altschul et al. (Altschul 1990, J. MoI. Biol. 215:403-10). BLAST using
acyltransferase nucleic acid sequences of the invention as query sequence can be
performed with the BLASTn, BLASTx or the tBLASTx program using default parameters to
obtain either nucleotide sequences (BLASTn, tBLASTx) or amino acid sequences (BLASTx)
homologous to acyltransferase sequences of the invention. BLAST using acyltransferase
protein sequences of the invention as query sequence can be performed with the BLASTp
or the tBLASTn program using default parameters to obtain either amino acid sequences
(BLASTp) or nucleic acid sequences (tBLASTn) homologous to acyltransferase sequences
of the invention. To obtain gapped alignments for comparison purposes, Gapped BLAST
using default parameters can be utilized as described in Altschul et al. (Altschul 1997,
Nucleic Acids Res. 25(17):3389-3402).
Table 1: Relation of sequence types of querry and hit sequences for various BLASt
programs
A polynucleotide comprising a fragment of any of the aforementioned nucleic acid
sequences is also encompassed as a polynucleotide of the present invention. The fragment
shall encode a polypeptide which still has desaturase and elongase activity as specified
above. Accordingly, the polypeptide may comprise or consist of the domains of the
polypeptide of the present invention conferring the said biological activity. A fragment as
meant herein, preferably, comprises at least 50, at least 100, at least 250 or at least 500
consecutive nucleotides of any one of the aforementioned nucleic acid sequences or
encodes an amino acid sequence comprising at least 20, at least 30, at least 50, at least
80, at least 100 or at least 150 consecutive amino acids of any one of the aforementioned
amino acid sequences.
The variant polynucleotides or fragments referred to above, preferably, encode
polypeptides retaining desaturase or elongase activity to a significant extent, preferably, at
least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least
70%, at least 80% or at least 90% of the desaturase and elongase activity exhibited by any
of the polypeptide shown in any one of SEQ ID NOs: 2 , 4 , 6, 8 or 10. The activity may be
tested as described in the accompanying Examples.
The polynucleotides of the present invention either essentially consist of the
aforementioned nucleic acid sequences or comprise the aforementioned nucleic acid
sequences. Thus, they may contain further nucleic acid sequences as well. Preferably, the
polynucleotide of the present invention may comprise in addition to an open reading frame
further untranslated sequence at the 3' and at the 5' terminus of the coding gene region:
at least 500, preferably 200, more preferably 100 nucleotides of the sequence upstream of
the 5' terminus of the coding region and at least 100, preferably 50, more preferably 20
nucleotides of the sequence downstream of the 3' terminus of the coding gene region.
Furthermore, the polynucleotides of the present invention may encode fusion proteins
wherein one partner of the fusion protein is a polypeptide being encoded by a nucleic acid
sequence recited above. Such fusion proteins may comprise as additional part other
enzymes of the fatty acid or PUFA biosynthesis pathways, polypeptides for monitoring
expression (e.g., green, yellow, blue or red fluorescent proteins, alkaline phosphatase and
the like) or so called " tags" which may serve as a detectable marker or as an auxiliary
measure for purification purposes. Tags for the different purposes are well known in the art
and comprise FLAG-tags, 6-histidine-tags, MYC-tags and the like.
The polynucleotide of the present invention shall be provided, preferably, either as an
isolated polynucleotide (i.e. purified or at least isolated from its natural context such as its
natural gene locus) or in genetically modified or exogenously (i.e. artificially) manipulated
form. An isolated polynucleotide can, for example, comprise less than approximately 5 kb, 4
kb, 3 kb, 2 kb, 1 kb, 0.5 kb or 0.1 kb of nucleotide sequences which naturally flank the
nucleic acid molecule in the genomic DNA of the cell from which the nucleic acid is derived.
The polynucleotide, preferably, is provided in the form of double or single stranded
molecule. It will be understood that the present invention by referring to any of the
aforementioned polynucleotides of the invention also refers to complementary or reverse
complementary strands of the specific sequences or variants thereof referred to before. The
polynucleotide encompasses DNA, including cDNA and genomic DNA, or RNA
polynucleotides.
However, the present invention also pertains to polynucleotide variants which are derived
from the polynucleotides of the present invention and are capable of interefering with the
transcription or translation of the polynucleotides of the present invention. Such variant
polynucleotides include anti-sense nucleic acids, ribozymes, siRNA molecules, morpholino
nucleic acids (phosphorodiamidate morpholino oligos), triple-helix forming oligonucleotides,
inhibitory oligonucleotides, or micro RNA molecules all of which shall specifically recognize
the polynucleotide of the invention due to the presence of complementary or substantially
complementary sequences. These techniques are well known to the skilled artisan. Suitable
variant polynucleotides of the aforementioned kind can be readily designed based on the
structure of the polynucleotides of this invention.
Moreover, comprised are also chemically modified polynucleotides including naturally
occurring modified polynucleotides such as glycosylated or methylated polynucleotides or
artificial modified ones such as biotinylated polynucleotides.
In the studies underlying the present invention, advantageously, polynucleotides where
identified encoding desaturase and elongases from Emiliana huxleyi. In particular, the
Emiliana huxleyi desaturases ∆4Des(Eh), ∆8Des(Eh) and ∆5Des(Eh) and elongases
∆9Elo(Eh) and ∆5Elo(Eh) have been identified. Each of the desaturases are capable of
introducing a double bond into fatty acids. For example, the expression of the ∆8Des(Eh)
leads to introduction of a double bond at position eight into C20:2n-6 fatty acid. The
polynucleotides of the present invention are particularly suitable for the recombinant
manufacture of LCPUFAs and, in particular, ARA, EPA and/or DHA.
In a preferred embodiment of the polynucleotide of the present invention, said
polynucleotide further comprises an expression control sequence operatively linked to the
said nucleic acid sequence.
The term " expression control sequence" as used herein refers to a nucleic acid
sequence which is capable of governing, i.e. initiating and controlling, transcription of a
nucleic acid sequence of interest, in the present case the nucleic sequences recited above.
Such a sequence usually comprises or consists of a promoter or a combination of a
promoter and enhancer sequences. Expression of a polynucleotide comprises transcription
of the nucleic acid molecule, preferably, into a translatable mRNA. Additional regulatory
elements may include transcriptional as well as translational enhancers. The following
promoters and expression control sequences may be, preferably, used in an expression
vector according to the present invention. The cos, tac, trp, tet, trp-tet, Ipp, lac, Ipp-lac,
laclq, T7, T5, T3, gal, trc, ara, SP6, λ -PR or λ -PL promoters are, preferably, used in
Gram-negative bacteria. For Gram-positive bacteria, promoters amy and SPO2 may be
used. From yeast or fungal promoters ADC1 , AOX1 r, GAL1 , MFa , AC, P-60, CYC1 ,
GAPDH, TEF, rp28, ADH are, preferably, used. For animal cell or organism expression, the
promoters CMV-, SV40-, RSV-promoter (Rous sarcoma virus), CMV-enhancer, SV40-
enhancer are preferably used. From plants the promoters CaMV/35S (Franck 1980, Cell 2 1 :
285-294], PRP1 (Ward 1993, Plant. MoI. Biol. 22), SSU, OCS, Iib4, usp, STLS1 , B33, nos
or the ubiquitin or phaseolin promoter. Also preferred in this context are inducible
promoters, such as the promoters described in EP 0 388 186 A 1 (i.e. a benzylsulfonamide-
inducible promoter), Gatz 1992, Plant J. 2:397-404 (i.e. a tetracyclin-inducible promoter),
EP 0 335 528 A 1 ( i.e. a abscisic-acid-inducible promoter) or WO 93/21334 (i.e. a ethanol-
or cyclohexenol-inducible promoter). Further suitable plant promoters are the promoter of
cytosolic FBPase or the ST-LSI promoter from potato (Stockhaus 1989, EMBO J. 8 , 2445),
the phosphoribosyl-pyrophosphate amidotransferase promoter from Glycine max (Genbank
accession No. U87999) or the node-specific promoter described in EP 0 249 676 A 1.
Particularly preferred are promoters which enable the expression in tissues which are
involved in the biosynthesis of fatty acids. Also particularly preferred are seed-specific
promoters such as the USP promoter in accordance with the practice, but also other
promoters such as the LeB4, DC3, phaseolin or napin promoters. Further especially
preferred promoters are seed-specific promoters which can be used for monocotyledonous
or dicotyledonous plants and which are described in US 5,608,152 (napin promoter from
oilseed rape), WO 98/45461 (oleosin promoter from Arobidopsis, US 5,504,200 (phaseolin
promoter from Phaseolus vulgaris), WO 91/13980 (Bce4 promoter from Brassica), by
Baeumlein et al., Plant J., 2 , 2 , 1992:233-239 (LeB4 promoter from a legume), these
promoters being suitable for dicots. The following promoters are suitable for monocots: lpt-2
or lpt-1 promoter from barley (WO 95/1 5389 and WO 95/23230), hordein promoter from
barley and other promoters which are suitable and which are described in WO 99/16890. In
principle, it is possible to use all natural promoters together with their regulatory sequences,
such as those mentioned above, for the novel process. Likewise, it is possible and
advantageous to use synthetic promoters, either additionally or alone, especially when they
mediate a seed-specific expression, such as, for example, as described in WO 99/16890. In
a particular embodiment, seed-specific promoters are utilized to enhance the production of
the desired PUFA or LCPUFA.
The term " operatively linked" as used herein means that the expression control
sequence and the nucleic acid of interest are linked so that the expression of the said
nucleic acid of interest can be governed by the said expression control sequence, i.e. the
expression control sequence shall be functionally linked to the said nucleic acid sequence
to be expressed. Accordingly, the expression control sequence and, the nucleic acid
sequence to be expressed may be physically linked to each other, e.g., by inserting the
expression control sequence at the 5 ' end of the nucleic acid sequence to be expressed.
Alternatively, the expression control sequence and the nucleic acid to be expressed may be
merely in physical proximity so that the expression control sequence is capable of
governing the expression of at least one nucleic acid sequence of interest. The expression
control sequence and the nucleic acid to be expressed are, preferably, separated by not
more than 500 bp, 300 bp, 100 bp, 80 bp, 60 bp, 40 bp, 20 bp, 10 bp or 5 bp.
In a further preferred embodiment of the polynucleotide of the present invention, said
polynucleotide further comprises a terminator sequence operatively linked to the nucleic
acid sequence.
The term " terminator" as used herein refers to a nucleic acid sequence which is capable
of terminating transcription. These sequences will cause dissociation of the transcription
machinery from the nucleic acid sequence to be transcribed. Preferably, the terminator shall
be active in plants and, in particular, in plant seeds. Suitable terminators are known in the
art and, preferably, include polyadenylation signals such as the SV40-poly-A site or the tk-
poly-A site or one of the plant specific signals indicated in Loke et al. (Loke 2005, Plant
Physiol 138, pp. 1457-1468), downstream of the nucleic acid sequence to be expressed.
The present invention also relates to a vector comprising the polynucleotide of the present
invention.
The term " vector" , preferably, encompasses phage, plasmid, viral vectors as well as
artificial chromosomes, such as bacterial or yeast artificial chromosomes. Moreover, the
term also relates to targeting constructs which allow for random or site- directed integration
of the targeting construct into genomic DNA. Such target constructs, preferably, comprise
DNA of sufficient length for either homolgous or heterologous recombination as described in
detail below. The vector encompassing the polynucleotide of the present invention,
preferably, further comprises selectable markers for propagation and/or selection in a host.
The vector may be incorporated into a host cell by various techniques well known in the art.
If introduced into a host cell, the vector may reside in the cytoplasm or may be incorporated
into the genome. In the latter case, it is to be understood that the vector may further
comprise nucleic acid sequences which allow for homologous recombination or
heterologous insertion. Vectors can be introduced into prokaryotic or eukaryotic cells via
conventional transformation or transfection techniques. The terms " transformation" and
" transfection" , conjugation and transduction, as used in the present context, are intended
to comprise a multiplicity of prior-art processes for introducing foreign nucleic acid (for
example DNA) into a host cell, including calcium phosphate, rubidium chloride or calcium
chloride co-precipitation, DEAE-dextran-mediated transfection, lipofection, natural
competence, carbon-based clusters, chemically mediated transfer, electroporation or
particle bombardment. Suitable methods for the transformation or transfection of host cells,
including plant cells, can be found in Sambrook et al. (Molecular Cloning: A Laboratory
Manual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, NY, 1989) and other laboratory manuals, such as Methods in Molecular
Biology, 1995, Vol. 44, Agrobacterium protocols, Ed.: Gartland and Davey, Humana Press,
Totowa, New Jersey. Alternatively, a plasmid vector may be introduced by heat shock or
electroporation techniques. Should the vector be a virus, it may be packaged in vitro using
an appropriate packaging cell line prior to application to host cells.
Preferably, the vector referred to herein is suitable as a cloning vector, i.e. replicable in
microbial systems. Such vectors ensure efficient cloning in bacteria and, preferably, yeasts
or fungi and make possible the stable transformation of plants. Those which must be
mentioned are, in particular, various binary and co-integrated vector systems which are
suitable for the T-DNA-mediated transformation. Such vector systems are, as a rule,
characterized in that they contain at least the vir genes, which are required for the
Agrobacterium-mediated transformation, and the sequences which delimit the T-DNA (T-
DNA border). These vector systems, preferably, also comprise further cis-regulatory regions
such as promoters and terminators and/or selection markers with which suitable
transformed host cells or organisms can be identified. While co-integrated vector systems
have vir genes and T-DNA sequences arranged on the same vector, binary systems are
based on at least two vectors, one of which bears vir genes, but no T-DNA, while a second
one bears T-DNA, but no vir gene. As a consequence, the last-mentioned vectors are
relatively small, easy to manipulate and can be replicated both in E . coli and in
Agrobacterium. These binary vectors include vectors from the pBIB-HYG, pPZP, pBecks,
pGreen series. Preferably used in accordance with the invention are Bin19, pBI1 0 1 ,
pBinAR, pGPTV and pCAMBIA. An overview of binary vectors and their use can be found in
Hellens et al, Trends in Plant Science (2000) 5 , 446- 451 . Furthermore, by using
appropriate cloning vectors, the polynucleotides can be introduced into host cells or
organisms such as plants or animals and, thus, be used in the transformation of plants,
such as those which are published, and cited, in: Plant Molecular Biology and
Biotechnology (CRC Press, Boca Raton, Florida), chapter 6/7, pp. 71-1 19 (1993); F.F.
White, Vectors for Gene Transfer in Higher Plants; in: Transgenic Plants, vol. 1,
Engineering and Utilization, Ed.: Kung and R. Wu, Academic Press, 1993, 15-38; B. Jenes
et al., Techniques for Gene Transfer, in: Transgenic Plants, vol. 1, Engineering and
Utilization, Ed.: Kung and R. Wu, Academic Press (1993), 128-143; Potrykus 1991, Annu.
Rev. Plant Physiol. Plant Molec. Biol. 42, 205-225.
More preferably, the vector of the present invention is an expression vector. In such an
expression vector, i.e. a vector which comprises the polynucleotide of the invention having
the nucleic acid sequence operatively linked to an expression control sequence (also called
" expression cassette" ) allowing expression in prokaryotic or eukaryotic cells or isolated
fractions thereof. Suitable expression vectors are known in the art such as Okayama-Berg
cDNA expression vector pcDV1 (Pharmacia), pCDMδ , pRc/CMV, pcDNAI , pcDNA3
(Invitrogene) or pSPORTI (GIBCO BRL). Further examples of typical fusion expression
vectors are pGEX (Pharmacia Biotech Inc; Smith 1988, Gene 67:31-40), pMAL (New
England Biolabs, Beverly, MA) and pRIT5 (Pharmacia, Piscataway, NJ), where glutathione
S-transferase (GST), maltose E-binding protein and protein A , respectively, are fused with
the recombinant target protein. Examples of suitable inducible nonfusion E . coli expression
vectors are, inter alia, pTrc (Amann 1988, Gene 69:301-315) and pET 11d (Studier 1990,
Methods in Enzymology 185, 60-89). The target gene expression of the pTrc vector is
based on the transcription from a hybrid trp-lac fusion promoter by host RNA polymerase.
The target gene expression from the pET 11d vector is based on the transcription of a T7-
gn10-lac fusion promoter, which is mediated by a coexpressed viral RNA polymerase (T7
gn1). This viral polymerase is provided by the host strains BL21 (DE3) or HMS174 (DE3)
from a resident λ-prophage which harbors a T7 gn1 gene under the transcriptional control of
the lacUV 5 promoter. The skilled worker is familiar with other vectors which are suitable in
prokaryotic organisms; these vectors are, for example, in E. coli, pLG338, pACYC184, the
pBR series such as pBR322, the pUC series such as pUC18 or pUC19, the M 113mp series,
pKC30, pRep4, pHS1 , pHS2, pPLc236, pMBL24, pLG200, pUR290, plN-1111 13-B1 , λgt1 1 or
pBdCI, in Streptomyces plJ101 , plJ364, plJ702 or plJ361 , in Bacillus pUB1 10, pC194 or
pBD214, in Corynebacterium pSA77 or pAJ667. Examples of vectors for expression in the
yeast S. cerevisiae comprise pYep Sec1 (Baldari 1987, Embo J. 6:229-234), pMFa (Kurjan
1982, Cell 30:933-943), pJRY88 (Schultz 1987, Gene 54:1 13-123) and pYES2 (Invitrogen
Corporation, San Diego, CA). Vectors and processes for the construction of vectors which
are suitable for use in other fungi, such as the filamentous fungi, comprise those which are
described in detail in: van den Hondel, C.A.M.J .J., & Punt, PJ. (1991) " Gene transfer
systems and vector development for filamentous fungi, in: Applied Molecular Genetics of
fungi, J.F. Peberdy et al., Ed., pp. 1-28, Cambridge University Press: Cambridge, or in:
More Gene Manipulations in Fungi (J.W. Bennett & L .L . Lasure, Ed., pp. 396-428:
Academic Press: San Diego). Further suitable yeast vectors are, for example, pAG-1 , YEp6,
YEp13 or pEMBLYe23. As an alternative, the polynucleotides of the present invention can
be also expressed in insect cells using baculovirus expression vectors. Baculovirus vectors
which are available for the expression of proteins in cultured insect cells (for example Sf9
cells) comprise the pAc series (Smith 1983, MoI. Cell Biol. 3:2156-2165) and the pVL series
(Lucklow 1989, Virology 170:31-39).
The polynucleotide of the present invention can be expressed in single-cell plant cells (such
as algae), see Falciatore 1999, Marine Biotechnology 1 (3):239-251 and the references
cited therein, and plant cells from higher plants (for example Spermatophytes, such as
arable crops) by using plant expression vectors. Examples of plant expression vectors
comprise those which are described in detail in: Becker 1992, Plant MoI. Biol. 20:1 195-
1197; Bevan 1984, Nucl. Acids Res. 12:871 1-8721 ; Vectors for Gene Transfer in Higher
Plants; in: Transgenic Plants, Vol. 1, Engineering and Utilization, Ed.: Kung and R. Wu,
Academic Press, 1993, p. 15-38. A plant expression cassette, preferably, comprises
regulatory sequences which are capable of controlling the gene expression in plant cells
and which are functionally linked so that each sequence can fulfill its function, such as
transcriptional termination, for example polyadenylation signals. Preferred polyadenylation
signals are those which are derived from Agrobacterium tumefaciens T-DNA, such as the
gene 3 of the Ti plasmid pTiACH , which is known as octopine synthase (Gielen 1984,
EMBO J . 3 , 835) or functional equivalents of these, but all other terminators which are
functionally active in plants are also suitable. Since plant gene expression is very often not
limited to transcriptional levels, a plant expression cassette preferably comprises other
functionally linked sequences such as translation enhancers, for example the overdrive
sequence, which comprises the 5' -untranslated tobacco mosaic virus leader sequence,
which increases the protein/RNA ratio (GaINe 1987, Nucl. Acids Research 15:8693-871 1).
As described above, plant gene expression must be functionally linked to a suitable
promoter which performs the expression of the gene in a timely, cell-specific or tissue-
specific manner. Promoters which can be used are constitutive promoters (Benfey 1989,
EMBO J . 8:2195-2202) such as those which are derived from plant viruses such as 35S
CAMV (Franck 1980, Cell 2 1 :285-294), 19S CaMV (see US 5,352,605 and WO 84/02913)
or plant promoters such as the promoter of the Rubisco small subunit, which is described in
US 4,962,028. Other preferred sequences for the use in functional linkage in plant gene
expression cassettes are targeting sequences which are required for targeting the gene
product into its relevant cell compartment (for a review, see Kermode 1996, Crit. Rev. Plant
Sci. 15, 4 : 285-423 and references cited therein), for example into the vacuole, the nucleus,
all types of plastids, such as amyloplasts, chloroplasts, chromoplasts, the extracellular
space, the mitochondria, the endoplasmic reticulum, oil bodies, peroxisomes and other
compartments of plant cells. As described above, plant gene expression can also be
facilitated via a chemically inducible promoter (for a review, see Gatz 1997, Annu. Rev.
Plant Physiol. Plant MoI. Biol., 48:89-108). Chemically inducible promoters are particularly
suitable if it is desired that genes are expressed in a time-specific manner. Examples of
such promoters are a salicylic-add-inducible promoter (WO 95/19443), a tetracyclin-
inducible promoter (Gatz 1992, Plant J . 2 , 397-404) and an ethanol-inducible promoter.
Promoters which respond to biotic or abiotic stress conditions are also suitable promoters,
for example the pathogen-induced PRP1 -gene promoter (Ward 1993, Plant MoI. Biol.
22:361-366), the heat-inducible hspδOpromoter from tomato (US 5,187,267), the cold-
inducible alpha-amylase promoter from potato (WO 96/12814) or the wound-inducible pinll
promoter (EP 0 375 091 A). The promoters which are especially preferred are those which
bring about the expression of genes in tissues and organs in which fatty acid, lipid and oil
biosynthesis takes place, in seed cells such as the cells of endosperm and of the
developing embryo. Suitable promoters are the napin gene promoter from oilseed rape (US
5,608,152), the USP promoter from Vicia faba (Baeumlein 1991 , MoI. Gen. Genet. 225
(3):459-67), the oleosin promoter from Arabidopsis (WO 98/45461), the phaseolin promoter
from Phaseolus vulgaris (US 5,504,200), the Bce4 promoter from Brassica (WO 91/13980)
or the legumin B4 promoter (LeB4; Baeumlein 1992, Plant Journal, 2 (2):233-9), and
promoters which bring about the seed-specific expression in monocotyledonous plants such
as maize, barley, wheat, rye, rice and the like. Suitable promoters to be taken into
consideration are the Ipt2 or Ipt1 gene promoter from barley (WO 95/15389 and WO
95/23230) or those which are described in WO 99/16890 (promoters from the barley
hordein gene, the rice glutelin gene, the rice oryzin gene, the rice prolamin gene, the wheat
gliadin gene, wheat glutelin gene, the maize zein gene, the oat glutelin gene, the sorghum
kasirin gene, the rye secalin gene). Likewise, especially suitable are promoters which bring
about the plastid-specific expression since plastids are the compartment in which the
precursors and some end products of lipid biosynthesis are synthesized. Suitable promoters
such as the viral RNA-polymerase promoter, are described in WO 95/16783 and WO
97/06250, and the clpP promoter from Arabidopsis, described in WO 99/46394.
The abovementioned vectors are only a small overview of vectors to be used in accordance
with the present invention. Further vectors are known to the skilled worker and are
described, for example, in: Cloning Vectors (Ed., Pouwels, P.H., et al., Elsevier,
Amsterdam-New York-Oxford, 1985, ISBN 0 444 90401 8). For further suitable expression
systems for prokaryotic and eukaryotic cells see the chapters 16 and 17 of Sambrook, loc
cit.
It follows from the above that, preferably, said vector is an expression vector. More
preferably, the said polynucleotide of the present invention is under the control of a seed-
specific promoter in the vector of the present invention. A preferred seed-specific promoter
as meant herein is selected from the group consisting of Conlinin 1, Conlinin 2 , napin,
LuFad3, USP, LeB4, Arc, Fae, ACP, LuPXR, and SBP. For details, see, e.g., US 2003-
0159174.
Moreover, the present invention relates to a host cell comprising the polynucleotide or the
vector of the present invention.
Preferably, said host cell is a plant cell and, more preferably, a plant cell obtained from an
oilseed crop. More preferably, said oilseed crop is selected from the group consisting of flax
(Linum sp.), rapeseed (Brassica sp.), soybean (Glycine sp.), sunflower (Helianthus sp.),
cotton (Gossypium sp.), corn (Zea mays), olive (Olea sp.), safflower (Carthamus sp.), cocoa
(Theobroma cacoa), peanut (Arachis sp.), hemp, camelina, crambe, oil palm, coconuts,
groundnuts, sesame seed, castor bean, lesquerella, tallow tree, sheanuts, tungnuts, kapok
fruit, poppy seed, jojoba seeds and perilla.
Also preferably, said host cell is a microorganism. More preferably, said microorganism is a
bacterium, a fungus or algae. More preferably, it is selected from the group consisting of
Candida, Cryptococcus, Lipomyces, Rhodosporidium, Yarrowia and Schizochytrium.
Moreover, a host cell according to the present invention may also be an animal cell.
Preferably, said animal host cell is a host cell of a fish or a cell line obtained therefrom.
More preferably, the fish host cell is from herring, salmon, sardine, redfish, eel, carp, trout,
halibut, mackerel, zander or tuna.
Generally, the controlling steps in the production of LCPUFAs, i.e., the long chain
unsaturated fatty acid biosynthetic pathway, are catalyzed by membrane-associated fatty
acid desaturases and elongases. Plants and most other eukaryotic organisms have
specialized desaturase and elongase systems for the introduction of double bonds and the
extension of fatty acids beyond C18 atoms. The elongase reactions have several important
features in common with the fatty acid synthase complex (FAS). However, the elongase
complex is different from the FAS complex as the complex is localized in the cytosol and
membrane bound, ACP is not involved and the elongase 3-keto-acyl-CoA-synthase
catalyzes the condensation of malonyl-CoA with an acyl primer. The elongase complex
consists of four components with different catalytic functions, the keto-acyl-synthase
(condensation reaction of malonyl-CoA to acyl-CoA, creation of a 2 C atom longer keto-
acyl-CoA fatty acid), the keto-acyl-reductase (reduction of the 3-keto group to a 3-hydroxy-
group), the dehydratase (dehydration results in a 3-enoyl-acyl-CoA fatty acid) and the
enoly-CoA-reductase (reduction of the double bond at position 3 , release from the
complex). For the production of LCPUFAs including ARA, EPA and/or DHA the elongation
reactions, beside the desaturation reactions, are essential. Higher plants do not have the
necessary enzyme set to produce LCPUFAs (4 or more double bonds, 20 or more C
atoms). Therefore the catalytic activities have to be conferred to the plants or plant cells.
The polynucleotides of the present invention catalyze the desaturation and elongation
activities necessary for the formation of ARA, EPA and/or DHA. By delivering the novel
desaturases and elongases increased levels of PUFAs and LCPUFAs are produced.
However, person skilled in the art knows that dependent on the host cell, further, enzymatic
activities may be conferred to the host cells, e.g., by recombinant technologies. Accordingly,
the present invention, preferably, envisages a host cell which in addition to the
polynucleotide of the present invention comprises polynucleotides encoding such
desaturases and/or elongases as required depending on the selected host cell. Preferred
desaturases and/or elongases which shall be present in the host cell are at least one
enzyme selected from the group consisting of: ∆ -4-desaturase, ∆ -5-desaturase, ∆ -5-
elongase, ∆ -6-desaturase, ∆12-desaturase, ∆15-desaturase, ω3-desaturase and ∆ -6-
elongase. Especially prefered are the bifunctional d12d15-Desaturases d12d15Des(Ac)
from Acanthamoeba castellanii (WO2007042510), d12d15Des(Cp) from Claviceps purpurea
(WO2008006202) and d12d15Des(Lg)1 from Lottia gigantea (WO20090 16202), the d12-
Desaturases d12Des(Co) from Calendula officinalis (WO2001 85968), d12Des(Lb) from
Laccaria bicolor (WO20090 16202), d12Des(Mb) from Monosiga brevicollis
(WO20090 16202), d12Des(Mg) from Mycosphaerella graminicola (WO2009016202),
d12Des(Nh) from Nectria haematococca (WO2009016202), d12Des(OI) from Ostreococcus
lucimarinus (WO2008040787), d12Des(Pb) from Phycomyces blakesleeanus
(WO20090 16202), d12Des(Ps) from Phytophthora sojae (WO20061 00241) and
d12Des(Tp) from Thalassiosira pseudonana (WO2006069710), the d15-Desaturases
d15Des(Hr) from Helobdella robusta (WO20090 16202), d15Des(Mc) from Microcoleus
chthonoplastes (WO2009016202), d15Des(Mf) from Mycosphaerella fijiensis
(WO20090 16202), d15Des(Mg) from Mycosphaerella graminicola (WO20090 16202) and
d15Des(Nh)2 from Nectria haematococca (WO2009016202), the d4-Desaturases
d4Des(Eg) from Euglena gracilis (WO2004090123), d4Des(Tc) from Thraustochytrium sp.
(WO2002026946) and d4Des(Tp) from Thalassiosira pseudonana (WO2006069710), the
d5-Desaturases d5Des(OI)2 from Ostreococcus lucimarinus (WO2008040787), d5Des(Pp)
from Physcomitrella patens (WO2004057001), d5Des(Pt) from Phaeodactylum tricornutum
(WO2002057465), d5Des(Tc) from Thraustochytrium sp. (WO2002026946), d5Des(Tp)
from Thalassiosira pseudonana (WO2006069710) and the d6-Desaturases d6Des(Cp) from
Ceratodon purpureus (WO2000075341), d6Des(OI) from Ostreococcus lucimarinus
(WO2008040787), d6Des(Ot) from Ostreococcus tauri (WO2006069710), d6Des(Pf) from
Primula farinosa (WO2003072784), d6Des(Pir)_BO from Pythium irregulare
(WO2002026946), d6Des(Pir) from Pythium irregulare (WO2002026946), d6Des(Plu) from
Primula luteola (WO2003072784), d6Des(Pp) from Physcomitrella patens (WO200 102591),
d6Des(Pt) from Phaeodactylum tricornutum (WO2002057465), d6Des(Pv) from Primula
vialii (WO2003072784) and d6Des(Tp) from Thalassiosira pseudonana (WO2006069710),
the d8-Desaturases d8Des(Ac) from Acanthamoeba castellanii (EP1 790731), dδDes(Eg)
from Euglena gracilis (WO200034439) and dδDes(Pm) from Perkinsus marinus
(WO2007093776), the o3-Desaturases o3Des(Pi) from Phytophthora infestans
(WO2005083053), o3Des(Pir) from Pythium irregulare (WO2008022963), o3Des(Pir)2 from
Pythium irregulare (WO2008022963) and o3Des(Ps) from Phytophthora sojae
(WO20061 00241), the bifunctional d5d6-elongases d5d6Elo(O ιm)2 from Oncorhynchus
mykiss (WO2005012316), d5d6Elo(Ta) from Thraustochytrium aureum (WO2005012316)
and d5d6Elo(Tc) from Thraustochytrium sp. (WO2005012316), the d5-elongases d5Elo(At)
from Arabidopsis thaliana (WO2005012316), d5Elo(At)2 from Arabidopsis thaliana
(WO2005012316), d5Elo(Ci) from Ciona intestinalis (WO2005012316), d5Elo(OI) from
Ostreococcus lucimarinus (WO2008040787), d5Elo(Ot) from Ostreococcus tauri
(WO2005012316), d5Elo(Tp) from Thalassiosira pseudonana (WO2005012316) and
d5Elo(XI) from Xenopus laevis (WO2005012316), the d6-elongases d6Elo(OI) from
Ostreococcus lucimarinus (WO2008040787), d6Elo(Ot) from Ostreococcus tauri
(WO2005012316), d6Elo(Pi) from Phytophthora infestans (WO2003064638), d6Elo(Pir)
from Pythium irregulare (WO2009016208), d6Elo(Pp) from Physcomitrella patens
(WO200 10591 28), d6Elo(Ps) from Phytophthora sojae (WO20061 00241), d6Elo(Ps)2 from
Phytophthora sojae (WO20061 00241), d6Elo(Ps)3 from Phytophthora sojae
(WO20061 00241), d6Elo(Pt) from Phaeodactylum tricornutum (WO2005012316), d6Elo(Tc)
from Thraustochytrium sp. (WO2005012316) and d6Elo(Tp) from Thalassiosira pseudonana
(WO2005012316), the d9-elongases d9Elo(lg) from lsochrysis galbana (WO2002077213),
d9Elo(Pm) from Perkinsus marinus (WO2007093776) and d9Elo(Ro) from Rhizopus oryzae
(WO2009016208). Particularly, if the manufuacture of ARA is envisaged in higher plants,
the enzymes recited in Table 3 , below (i.e. aditinonally a d6-desaturase, d6-elongase, d5-
elongase, d5-desaturase, d12-desaturase, and d6-elongase) or enzymes having essentially
the same activity may be combined in a host cell. If the manufacture of EPA is envisaged in
higher plants, the enzymes recited in Table 4 , below (i.e. aditinonally a d6-desaturase, d6-
elongase, d5-desaturase, d12-desaturase, d6-elongase, omega 3-desaturase and d15-
desaturase), or enzymes having essentially the same activity may be combined in a host
cell. If the manufacture of DHA is envisaged in higher plants, the enzymes recited in Table
5 , below (i.e. aditinonally a d6-desaturase, d6-elongase, d5-desaturase, d12-desaturase,
d6-elongase, omega 3-desaturase, d15-desaturase, d5-elongase, and d4-desaturase), or
enzymes having essentially the same activity may be combined in a host cell.
The present invention also relates to a cell, preferably a host cell as specified above or a
cell of a non-human organism specified elsewhere herein, said cell comprising a
polynucleotide which is obtained from the polynucleotide of the present invention by a point
mutation, a truncation, an inversion, a deletion, an addition, a substitution and homologous
recombination. How to carry out such modifications to a polynucleotide is well known to the
skilled artisan and has been described elsewhere in this specification in detail.
The present invention furthermore pertains to a method for the manufacture of a
polypeptide encoded by a polynucleotide of any the present invention comprising
a) cultivating the host cell of the invention under conditions which allow for the production
of the said polypeptide; and
b) obtaining the polypeptide from the host cell of step a).
Suitable conditions which allow for expression of the polynucleotide of the invention
comprised by the host cell depend on the host cell as well as the expression control
sequence used for governing expression of the said polynucleotide. These conditions and
how to select them are very well known to those skilled in the art. The expressed
polypeptide may be obtained, for example, by all conventional purification techniques
including affinity chromatography, size exclusion chromatography, high pressure liquid
chromatography (HPLC) and precipitation techniques including antibody precipitation. It is
to be understood that the method may - although preferred -not necessarily yield an
essentially pure preparation of the polypeptide. It is to be understood that depending on the
host cell which is used for the aforementioned method, the polypeptides produced thereby
may become posttranslationally modified or processed otherwise.
The present invention also encompasses a polypeptide encoded by the polynucleotide of of
the present invention or which is obtainable by the aforementioned method.
The term " polypeptide" as used herein encompasses essentially purified polypeptides or
polypeptide preparations comprising other proteins in addition. Further, the term also
relates to the fusion proteins or polypeptide fragments being at least partially encoded by
the polynucleotide of the present invention referred to above. Moreover, it includes
chemically modified polypeptides. Such modifications may be artificial modifications or
naturally occurring modifications such as phosphorylation, glycosylation, myristylation and
the like (Review in Mann 2003, Nat. Biotechnol. 2 1 , 255- 261 , review with focus on plants
in Huber 2004, Curr. Opin. Plant Biol. 7 , 318-322). Currently, more than 300
posttranslational modifications are known (see full ABFRC Delta mass list at
http://www.abrf.org/index.cfm/dm.home). The polypeptides of the present invention shall
exhibit the desaturase or elongase activitiy referred to above.
Encompassed by the present invention is, furthermore, an antibody or fragments thereof
which specifically recognizes the polypeptide of the invention.
Antibodies against the polypeptides of the invention can be prepared by well known
methods using a purified polypeptide according to the invention or a suitable fragment
derived therefrom as an antigen. A fragment which is suitable as an antigen may be
identified by antigenicity determining algorithms well known in the art. Such fragments may
be obtained either from the polypeptide of the invention by proteolytic digestion or may be a
synthetic peptide. Preferably, the antibody of the present invention is a monoclonal
antibody, a polyclonal antibody, a single chain antibody, a chimerized antibody or a
fragment of any of these antibodies, such as Fab, Fv or scFv fragments etc.. Also
comprised as antibodies by the present invention are bispecific antibodies, synthetic
antibodies or chemically modified derivatives of any of the aforementioned antibodies. The
antibody of the present invention shall specifically bind (i.e. does significantly not cross
react with other polypeptides or peptides) to the polypeptide of the invention. Specific
binding can be tested by various well known techniques. Antibodies or fragments thereof
can be obtained by using methods which are described, e.g., in Harlow and Lane
"Antibodies, A Laboratory Manual", CSH Press, Cold Spring Harbor, 1988. Monoclonal
antibodies can be prepared by the techniques originally described in Kδhler 1975, Nature
256, 495, and Galfre 1981 , Meth. Enzymol. 73, 3 , which comprise the fusion of mouse
myeloma cells to spleen cells derived from immunized mammals. The antibodies can be
used, for example, for the immunoprecipitation, immunolocalization or purification (e.g., by
affinity chromatography) of the polypeptides of the invention as well as for the monitoring of
the presence of said variant polypeptides, for example, in recombinant organisms, and for
the identification of proteins or compounds interacting with the proteins according to the
invention.
Moreover, the present invention contemplates a non-human transgenic organism
comprising the polynucleotide or the vector of the present invention.
Preferably, the non-human transgenic organism is a plant, plant part, or plant seed.
Preferred plants to be used for introducing the polynucleotide or the vector of the invention
are plants which are capable of synthesizing fatty acids, such as all dicotyledonous or
monocotyledonous plants, algae or mosses. It is to be understood that host cells derived
from a plant may also be used for producing a plant according to the present invention.
Preferred plants are selected from the group of the plant families Adelotheciaceae,
Anacardiaceae, Asteraceae, Apiaceae, Betulaceae, Boraginaceae, Brassicaceae,
Bromeliaceae, Caricaceae, Cannabaceae, Convolvulaceae, Chenopodiaceae,
Crypthecodiniaceae, Cucurbitaceae, Ditrichaceae, Elaeagnaceae, Ericaceae,
Euphorbiaceae, Fabaceae, Geraniaceae, Gramineae, Juglandaceae, Lauraceae,
Leguminosae, Linaceae, Prasinophyceae or vegetable plants or ornamentals such as
Tagetes. Examples which may be mentioned are the following plants selected from the
group consisting of: Adelotheciaceae such as the genera Physcomitrella, such as the genus
and species Physcomitrella patens, Anacardiaceae such as the genera Pistacia, Mangifera,
Anacardium, for example the genus and species Pistacia vera [pistachio], Mangifer indica
[mango] or Anacardium occidentale [cashew], Asteraceae, such as the genera Calendula,
Carthamus, Centaurea, Cichorium, Cynara, Helianthus, Lactuca, Locusta, Tagetes,
Valeriana, for example the genus and species Calendula officinalis [common marigold],
Carthamus tinctorius [safflower], Centaurea cyanus [cornflower], Cichorium intybus
[chicory], Cynara scolymus [artichoke], Helianthus annus [sunflower], Lactuca sativa,
Lactuca crispa, Lactuca esculenta, Lactuca scariola L. ssp. sativa, Lactuca scariola L. var.
integrata, Lactuca scariola L . var. integrifolia, Lactuca sativa subsp. romana, Locusta
communis, Valeriana locusta [salad vegetables], Tagetes lucida, Tagetes erecta or Tagetes
tenuifolia [african orfrench marigold], Apiaceae, such as the genus Daucus, for example
the genus and species Daucus carota [carrot], Betulaceae, such as the genus Corylus, for
example the genera and species Corylus avellana or Corylus colurna [hazelnut],
Boraginaceae, such as the genus Borago, for example the genus and species Borago
officinalis [borage], Brassicaceae, such as the genera Brassica, Melanosinapis, Sinapis,
Arabadopsis, for example the genera and species Brassica napus, Brassica rapa ssp.
[oilseed rape], Sinapis arvensis Brassica juncea, Brassica juncea var. juncea, Brassica
juncea var. crispifolia, Brassica juncea var. foliosa, Brassica nigra, Brassica sinapioides,
Melanosinapis communis [mustard], Brassica oleracea [fodder beet] or Arabidopsis
thaliana, Bromeliaceae, such as the genera Anana, Bromelia (pineapple), for example the
genera and species Anana comosus, Ananas ananas or Bromelia comosa [pineapple],
Caricaceae, such as the genus Carica, such as the genus and species Carica papaya
[pawpaw], Cannabaceae, such as the genus Cannabis, such as the genus and species
Cannabis sativa [hemp], Convolvulaceae, such as the genera Ipomea, Convolvulus, for
example the genera and species lpomoea batatus, lpomoea pandurata, Convolvulus
batatas, Convolvulus tiliaceus, lpomoea fastigiata, lpomoea tiliacea, lpomoea triloba or
Convolvulus panduratus [sweet potato, batate], Chenopodiaceae, such as the genus Beta,
such as the genera and species Beta vulgaris, Beta vulgaris var. altissima, Beta vulgaris
var.Vulgaris, Beta maritima, Beta vulgaris var. perennis, Beta vulgaris var. conditiva or Beta
vulgaris var. esculenta [sugarbeet], Crypthecodiniaceae, such as the genus
Crypthecodinium, for example the genus and species Cryptecodinium cohnii,
Cucurbitaceae, such as the genus Cucurbita, for example the genera and species
Cucurbita maxima, Cucurbita mixta, Cucurbita pepo or Cucurbita moschata
[pumpkin/squash], Cymbellaceae such as the genera Amphora, Cymbella, Okedenia,
Phaeodactylum, Reimeria, for example the genus and species Phaeodactylum tricornutum,
Ditrichaceae such as the genera Ditrichaceae, Astomiopsis, Ceratodon, Chrysoblastella,
Ditrichum, Distichium, Eccremidium, Lophidion, Philibertiella, Pleuridium, Saelania,
Trichodon, Skottsbergia, for example the genera and species Ceratodon antarcticus,
Ceratodon columbiae, Ceratodon heterophyllus, Ceratodon purpureus, Ceratodon
purpureus, Ceratodon purpureus ssp. convolutus, Ceratodon, purpureus spp. stenocarpus,
Ceratodon purpureus var. rotundifolius, Ceratodon ratodon, Ceratodon stenocarpus,
Chrysoblastella chilensis, Ditrichum ambiguum, Ditrichum brevisetum, Ditrichum
crispatissimum, Ditrichum difficile, Ditrichum falcifolium, Ditrichum flexicaule, Ditrichum
giganteum, Ditrichum heteromallum, Ditrichum lineare, Ditrichum lineare, Ditrichum
montanum, Ditrichum montanum, Ditrichum pallidum, Ditrichum punctulatum, Ditrichum
pusillum, Ditrichum pusillum var. tortile, Ditrichum rhynchostegium, Ditrichum schimperi,
Ditrichum tortile, Distichium capillaceum, Distichium hagenii, Distichium inclinatum,
Distichium macounii, Eccremidium floridanum, Eccremidium whiteleggei, Lophidion strictus,
Pleuridium acuminatum, Pleuridium altemifolium, Pleuridium holdridgei, Pleuridium
mexicanum, Pleuridium ravenelii, Pleuridium subulatum, Saelania glaucescens, Trichodon
borealis, Trichodon cylindricus or Trichodon cylindricus var. oblongus, Elaeagnaceae such
as the genus Elaeagnus, for example the genus and species Olea europaea [olive],
Ericaceae such as the genus Kalmia, for example the genera and species Kalmia latifolia,
Kalmia angustifolia, Kalmia microphylla, Kalmia polifolia, Kalmia occidentalis, Cistus
chamaerhodendros or Kalmia lucida [mountain laurel], Euphorbiaceae such as the genera
Manihot, Janipha, Jatropha, Ricinus, for example the genera and species Manihot
utilissima, Janipha manihot, Jatropha manihot, Manihot aipil, Manihot dulcis, Manihot
manihot, Manihot melanobasis, Manihot esculenta [manihot] or Ricinus communis [castor-
oil plant], Fabaceae such as the genera Pisum, Albizia, Cathormion, Feuillea, Inga,
Pithecolobium, Acacia, Mimosa, Medicajo, Glycine, Dolichos, Phaseolus, Soja, for example
the genera and species Pisum sativum, Pisum arvense, Pisum humile [pea], Albizia
berteriana, Albizia julibrissin, Albizia lebbeck, Acacia berteriana, Acacia littoralis, Albizia
berteriana, Albizzia berteriana, Cathormion berteriana, Feuillea berteriana, Inga fragrans,
Pithecellobium berterianum, Pithecellobium fragrans, Pithecolobium berterianum,
Pseudalbizzia berteriana, Acacia julibrissin, Acacia nemu, Albizia nemu, Feuilleea
julibrissin, Mimosa julibrissin, Mimosa speciosa, Sericanrda julibrissin, Acacia lebbeck,
Acacia macrophylla, Albizia lebbek, Feuilleea lebbeck, Mimosa lebbeck, Mimosa speciosa
[silk tree], Medicago sativa, Medicago falcata, Medicago varia [alfalfa], Glycine max
Dolichos soja, Glycine gracilis, Glycine hispida, Phaseolus max, Soja hispida or Soja max
[soybean], Funariaceae such as the genera Aphanorrhegma, Entosthodon, Funaria,
Physcomitrella, Physcomitrium, for example the genera and species Aphanorrhegma
serratum, Entosthodon attenuatus, Entosthodon bolanderi, Entosthodon bonplandii,
Entosthodon californicus, Entosthodon drummondii, Entosthodon jamesonii, Entosthodon
leibergii, Entosthodon neoscoticus, Entosthodon rubrisetus, Entosthodon spathulifolius,
Entosthodon tucsoni, Funaria americana, Funaria bolanderi, Funaria calcarea, Funaria
californica, Funaria calvescens, Funaria convoluta, Funaria flavicans, Funaria groutiana,
Funaria hygrometrica, Funaria hygrometrica var. arctica, Funaria hygrometrica var.
calvescens, Funaria hygrometrica var. convoluta, Funaria hygrometrica var. muralis,
Funaria hygrometrica var. utahensis, Funaria microstoma, Funaria microstoma var.
obtusifolia, Funaria muhlenbergii, Funaria orcuttii, Funaria plano-convexa, Funaria polaris,
Funaria ravenelii, Funaria rubriseta, Funaria serrata, Funaria sonorae, Funaria sublimbatus,
Funaria tucsoni, Physcomitrella californica, Physcomitrella patens, Physcomitrella readeri,
Physcomitrium australe, Physcomitrium californicum, Physcomitrium collenchymatum,
Physcomitrium coloradense, Physcomitrium cupuliferum, Physcomitrium drummondii,
Physcomitrium eurystomum, Physcomitrium flexifolium, Physcomitrium hookeri,
Physcomitrium hookeri var. serratum, Physcomitrium immersum, Physcomitrium
kellermanii, Physcomitrium megalocarpum, Physcomitrium pyriforme, Physcomitrium
pyriforme var. serratum, Physcomitrium rufipes, Physcomitrium sandbergii, Physcomitrium
subsphaericum, Physcomitrium washingtoniense, Geraniaceae, such as the genera
Pelargonium, Cocos, Oleum, for example the genera and species Cocos nucifera,
Pelargonium grossularioides or Oleum cocois [coconut], Gramineae, such as the genus
Saccharum, for example the genus and species Saccharum officinarum, Juglandaceae,
such as the genera Juglans, WaINa, for example the genera and species Juglans regia,
Juglans ailanthifolia, Juglans sieboldiana, Juglans cinerea, Wallia cinerea, Juglans bixbyi,
Juglans californica, Juglans hindsii, Juglans intermedia, Juglans jamaicensis, Juglans
major, Juglans microcarpa, Juglans nigra or Wallia nigra [walnut], Lauraceae, such as the
genera Persea, Laurus, for example the genera and species Laurus nobilis [bay], Persea
americana, Persea gratissima or Persea persea [avocado], Leguminosae, such as the
genus Arachis, for example the genus and species Arachis hypogaea [peanut], Linaceae,
such as the genera Linum, Adenolinum, for example the genera and species Linum
usitatissimum, Linum humile, Linum austriacum, Linum bienne, Linum angustifolium, Linum
catharticum, Linum flavum, Linum grandiflorum, Adenolinum grandiflorum, Linum lewisii,
Linum narbonense, Linum perenne, Linum perenne var. lewisii, Linum pratense or Linum
trigynum [linseed], Lythrarieae, such as the genus Punica, for example the genus and
species Punica granatum [pomegranate], Malvaceae, such as the genus Gossypium, for
example the genera and species Gossypium hirsutum, Gossypium arboreum, Gossypium
barbadense, Gossypium herbaceum or Gossypium thurberi [cotton], Marchantiaceae, such
as the genus Marchantia, for example the genera and species Marchantia berteroana,
Marchantia foliacea, Marchantia macropora, Musaceae, such as the genus Musa, for
example the genera and species Musa nana, Musa acuminata, Musa paradisiaca, Musa
spp. [banana], Onagraceae, such as the genera Camissonia, Oenothera, for example the
genera and species Oenothera biennis or Camissonia brevipes [evening primrose], Palmae,
such as the genus Elacis, for example the genus and species Elaeis guineensis [oil palm],
Papaveraceae, such as the genus Papaver, for example the genera and species Papaver
orientale, Papaver rhoeas, Papaver dubium [poppy], Pedaliaceae, such as the genus
Sesamum, for example the genus and species Sesamum indicum [sesame], Piperaceae,
such as the genera Piper, Artanthe, Peperomia, Steffensia, for example the genera and
species Piper aduncum, Piper amalago, Piper angustifolium, Piper auritum, Piper betel,
Piper cubeba, Piper longum, Piper nigrum, Piper retrofractum, Artanthe adunca, Artanthe
elongata, Peperomia elongata, Piper elongatum, Steffensia elongata [cayenne pepper],
Poaceae, such as the genera Hordeum, Secale, Avena, Sorghum, Andropogon, Holcus,
Panicum, Oryza, Zea (maize), Triticum, for example the genera and species Hordeum
vulgare, Hordeum jubatum, Hordeum murinum, Hordeum secalinum, Hordeum distichon,
Hordeum aegiceras, Hordeum hexastichon, Hordeum hexastichum, Hordeum irregulare,
Hordeum sativum, Hordeum secalinum [barley], Secale cereale [rye], Avena sativa, Avena
fatua, Avena byzantina, Avena fatua var. sativa, Avena hybrida [oats], Sorghum bicolor,
Sorghum halepense, Sorghum saccharatum, Sorghum vulgare, Andropogon drummondii,
Holcus bicolor, Holcus sorghum, Sorghum aethiopicum, Sorghum arundinaceum, Sorghum
caffrorum, Sorghum cernuum, Sorghum dochna, Sorghum drummondii, Sorghum durra,
Sorghum guineense, Sorghum lanceolatum, Sorghum nervosum, Sorghum saccharatum,
Sorghum subglabrescens, Sorghum verticilliflorum, Sorghum vulgare, Holcus halepensis,
Sorghum miliaceum, Panicum militaceum [millet], Oryza sativa, Oryza latifolia [rice], Zea
mays [maize], Triticum aestivum, Triticum durum, Triticum turgidum, Triticum hybemum,
Triticum macha, Triticum sativum or Triticum vulgare [wheat], Porphyridiaceae, such as the
genera Chroothece, Flintiella, Petrovanella, Porphyridium, Rhodella, Rhodosorus,
Vanhoeffenia, for example the genus and species Porphyridium cruentum, Proteaceae,
such as the genus Macadamia, for example the genus and species Macadamia intergrifolia
[macadamia], Prasinophyceae such as the genera Nephroselmis, Prasinococcus,
Scherffelia, Tetraselmis, Mantoniella, Ostreococcus, for example the genera and species
Nephroselmis olivacea, Prasinococcus capsulatus, Scherffelia dubia, Tetraselmis chui,
Tetraselmis suecica, Mantoniella squamata, Ostreococcus tauri, Rubiaceae such as the
genus Cofea, for example the genera and species Cofea spp., Coffea arabica, Coffea
canephora or Coffea liberica [coffee], Scrophulariaceae such as the genus Verbascum, for
example the genera and species Verbascum blattaria, Verbascum chaixii, Verbascum
densiflorum, Verbascum lagurus, Verbascum longifolium, Verbascum lychnitis, Verbascum
nigrum, Verbascum olympicum, Verbascum phlomoides, Verbascum phoenicum,
Verbascum pulverulentum or Verbascum thapsus [mullein], Solanaceae such as the genera
Capsicum, Nicotiana, Solanum, Lycopersicon, for example the genera and species
Capsicum annuum, Capsicum annuum var. glabriusculum, Capsicum frutescens [pepper],
Capsicum annuum [paprika], Nicotiana tabacum, Nicotiana alata, Nicotiana attenuata,
Nicotiana glauca, Nicotiana langsdorffii, Nicotiana obtusifolia, Nicotiana quadrivalvis,
Nicotiana repanda, Nicotiana rustica, Nicotiana sylvestris [tobacco], Solanum tuberosum
[potato], Solanum melongena [eggplant], Lycopersicon esculentum, Lycopersicon
lycopersicum, Lycopersicon pyriforme, Solanum integrifolium or Solanum lycopersicum
[tomato], Sterculiaceae, such as the genus Theobroma, for example the genus and species
Theobroma cacao [cacao] or Theaceae, such as the genus Camellia, for example the
genus and species Camellia sinensis [tea]. In particular preferred plants to be used as
transgenic plants in accordance with the present invention are oil fruit crops which comprise
large amounts of lipid compounds, such as peanut, oilseed rape, canola, sunflower,
safflower, poppy, mustard, hemp, castor-oil plant, olive, sesame, Calendula, Punica,
evening primrose, mullein, thistle, wild roses, hazelnut, almond, macadamia, avocado, bay,
pumpkin/squash, linseed, soybean, pistachios, borage, trees (oil palm, coconut, walnut) or
crops such as maize, wheat, rye, oats, triticale, rice, barley, cotton, cassava, pepper,
Tagetes, Solanaceae plants such as potato, tobacco, eggplant and tomato, Vicia species,
pea, alfalfa or bushy plants (coffee, cacao, tea), SaNx species, and perennial grasses and
fodder crops. Preferred plants according to the invention are oil crop plants such as peanut,
oilseed rape, canola, sunflower, safflower, poppy, mustard, hemp, castor-oil plant, olive,
Calendula, Punica, evening primrose, pumpkin/squash, linseed, soybean, borage, trees (oil
palm, coconut). Especially preferred are sunflower, safflower, tobacco, mullein, sesame,
cotton, pumpkin/squash, poppy, evening primrose, walnut, linseed, hemp, thistle or
safflower. Very especially preferred plants are plants such as safflower, sunflower, poppy,
evening primrose, walnut, linseed, or hemp.
Preferred mosses are Physcoimitrella or Ceratodon. Preferred algae are Isochrysis,
Mantoniella, Ostreococcus or Crypthecodinium, and algae/diatoms such as Phaeodactylum
or Thraustochytrium. More preferably, said algae or mosses are selected from the group
consisting of: Emiliana, Shewanella, Physcomitrella, Thraustochytrium, Fusarium,
Phytophthora, Ceratodon, Isochrysis, Aleurita, Muscarioides, Mortierella, Phaeodactylum,
Cryphthecodinium, specifically from the genera and species Thallasiosira pseudonona,
Euglena gracilis, Physcomitrella patens, Phytophtora infestans, Fusarium graminaeum,
Cryptocodinium cohnii, Ceratodon purpureus, Isochrysis galbana, Aleurita farinosa,
Thraustochytrium sp., Muscarioides viallii, Mortierella alpina, Phaeodactylum tricornutum or
Caenorhabditis elegans or especially advantageously Phytophtora infestans, Thallasiosira
pseudonona and Cryptocodinium cohnii.
Transgenic plants may be obtained by transformation techniques as elsewhere in this
specification. Preferably, transgenic plants can be obtained by T-DNA-mediated
transformation. Such vector systems are, as a rule, characterized in that they contain at
least the vir genes, which are required for the Agrobacterium-mediated transformation, and
the sequences which delimit the T-DNA (T-DNA border). Suitable vectors are described
elsewhere in the specification in detail.
Also encompassed are transgenic non-human animals comprising the vector or
polynucleotide of the present invention. Preferred non-human transgenic animals envisaged
by the present invention are fish, such as herring, salmon, sardine, redfish, eel, carp, trout,
halibut, mackerel, zander or tuna.
However, it will be understood that dependent on the non-human transgenic organism
specified above, further, enzymatic activities may be conferred to the said organism, e.g.,
by recombinant technologies. Accordingly, the present invention, preferably, envisages a
non-human transgenic organism specified above which in addition to the polynucleotide of
the present invention comprises polynucleotides encoding such desaturases and/or
elongases as required depending on the selected host cell. Preferred desaturases and/or
elongases which shall be present in the organism are at least one enzyme selected from
the group of desaturases and/or elongases or the combinations specifically recited
elsewhere in this specification (see above and Tables 3 4 and 5).
Furthermore, the present invention encompasses a method for the manufacture of
polyunsaturated fatty acids comprising:
a) cultivating the host cell of the invention under conditions which allow for the production
of polyunsaturated fatty acids in said host cell;
b) obtaining said polyunsaturated fatty acids from the said host cell.
The term " polyunsaturated fatty acids (PUFA)" as used herein refers to fatty acids
comprising at least two, preferably, three, four, five or six, double bonds. Moreover, it is to
be understood that such fatty acids comprise, preferably from 18 to 24 carbon atoms in the
fatty acid chain. More preferably, the term relates to long chain PUFA (LCPUFA) having
from 20 to 24 carbon atoms in the fatty acid chain. Preferred unsaturated fatty acids in the
sense of the present invention are selected from the group consisting of DGLA 20:3
(8,1 1,14), ARA 20:4 (5,8,1 1,14), iARA 20:4(8,1 1,14,17), EPA 20:5 (5,8,1 1,14,17), DPA 22:5
(4,7,10,13,16), DHA 22:6 (4,7,10,13,16,19), 20:4 (8,1 1,14,17), more preferably, arachidonic
acid (ARA) 20:4 (5,8,1 1,14), eicosapentaenoic acid (EPA) 20:5 (5,8,1 1,14,17), and
docosahexaenoic acid (DHA) 22:6 (4,7,10,13,16,19). Thus, it will be understood that most
preferably, the methods provided by the present invention pertaining to the manufacture of
ARA, EPA or DHA. Moreover, also encompassed are the intermediates of LCPUFA which
occur during synthesis. Such intermediates are, preferably, formed from substrates by the
desaturase or elongase activity of the polypeptides of the present invention. Preferably,
substrates encompass LA 18:2 (9,12), ALA 18:3(9,12,15), Eicosadienoic acid 20:2 ( 1 1,14),
Eicosatrienoic acid 20:3 ( 1 1,14,17)), DGLA 20:3 (8,1 1,14), ARA 20:4 (5,8,1 1,14),
eicosatetraenoic acid 20:4 (8,1 1,14,17), Eicosapentaenoic acid 20:5 (5,8,1 1,14,17),
Docosahexapentanoic acid 22:5 (7, 10 ,13 ,16 ,19).
The term " cultivating" as used herein refers maintaining and growing the host cells under
culture conditions which allow the cells to produce the said polyunsaturated fatty acid, i.e.
the PUFA and/or LCPUFA referred to above. This implies that the polynucleotide of the
present invention is expressed in the host cell so that the desaturase and/or elongase
activity is present. Suitable culture conditions for cultivating the host cell are described in
more detail below.
The term " obtaining" as used herein encompasses the provision of the cell culture
including the host cells and the culture medium as well as the provision of purified or
partially purified preparations thereof comprising the polyunsaturated fatty acids, preferably,
ARA, EPA, DHA, in free or in -CoA bound form, as membrane phospholipids or as
triacylglyceride estres. More preferably, the PUFA and LCPUFA are to be obtained as
triglyceride esters, e.g., in form of an oil. More details on purification techniques can be
found elsewhere herein below.
The host cells to be used in the method of the invention are grown or cultured in the manner
with which the skilled worker is familiar, depending on the host organism. Usually, host cells
are grown in a liquid medium comprising a carbon source, usually in the form of sugars, a
nitrogen source, usually in the form of organic nitrogen sources such as yeast extract or
salts such as ammonium sulfate, trace elements such as salts of iron, manganese and
magnesium and, if appropriate, vitamins, at temperatures of between O0C and 1000C,
preferably between 1O0C and 600C under oxygen or anaerobic atmosphere depedent on
the type of organism. The pH of the liquid medium can either be kept constant, that is to say
regulated during the culturing period, or not. The cultures can be grown batchwise,
semibatchwise or continuously. Nutrients can be provided at the beginning of the
fermentation or administerd semicontinuously or continuously: The produced PUFA or
LCPUFA can be isolated from the host cells as described above by processes known to the
skilled worker, e.g., by extraction, distillation, crystallization, if appropriate precipitation with
salt, and/or chromatography. It might be required to disrupt the host cells prior to
purification. To this end, the host cells can be disrupted beforehand. The culture medium to
be used must suitably meet the requirements of the host cells in question. Descriptions of
culture media for various microorganisms which can be used as host cells according to the
present invention can be found in the textbook "Manual of Methods for General
Bacteriology" of the American Society for Bacteriology (Washington D.C , USA, 1981).
Culture media can also be obtained from various commercial suppliers. All media
components are sterilized, either by heat or by filter sterilization. All media components may
be present at the start of the cultivation or added continuously or batchwise, as desired. If
the polynucleotide or vector of the invention which has been introduced in the host cell
further comprises an expressible selection marker, such as an antibiotic resistance gene, it
might be necessary to add a selection agent to the culture, such as a antibiotic in order to
maintain the stability of the introduced polynucleotide. The culture is continued until
formation of the desired product is at a maximum. This is normally achieved within 10 to
160 hours. The fermentation broths can be used directly or can be processed further. The
biomass may, according to requirement, be removed completely or partially from the
fermentation broth by separation methods such as, for example, centrifugation, filtration,
decanting or a combination of these methods or be left completely in said broth. The fatty
acid preparations obtained by the method of the invention, e.g., oils, comprising the desired
PUFA or LCPUFA as triglyceride esters are also suitable as starting material for the
chemical synthesis of further products of interest. For example, they can be used in
combination with one another or alone for the preparation of pharmaceutical or cosmetic
compositions, foodstuffs, or animal feeds. Chemically pure triglycerides comprising the
desired PUFA or LCPUFA can also be manufactured by the methods described above. To
this end, the fatty acid preparations are further purified by extraction, distillation,
crystallization, chromatography or combinations of these methods. In order to release the
fatty acid moieties from the triglycerides, hydrolysis may be also required. The said
chemically pure triglycerides or free fatty acids are, in particular, suitable for applications in
the food industry or for cosmetic and pharmacological compositions.
Moreover, the present invention relates to a method for the manufacture of poly
unsaturated fatty acids comprising:
a) cultivating the non-human transgenic organism of the invention under conditions
which allow for the production of poly-unsaturated fatty acids in said non-human
transgenic organism; and
b) obtaining said poly-unsaturated fatty acids from the said non-human transgenic
organism.
Further, it follows from the above that a method for the manufacture of an oil, lipid or fatty
acid composition is also envisaged by the present invention comprising the steps of any
one of the aforementioned methods and the further step of formulating PUFA or LCPUFA
as oil, lipid or fatty acid composition. Preferably, said oil, lipid or fatty acid composition is to
be used for feed, foodstuffs, cosmetics or medicaments. Accordingly, the formulation of the
PUFA or LCPUFA shall be carried out according to the GMP standards for the individual
envisaged products. For example, an oil may be obtained from plant seeds by an oil mill.
However, for product safety reasons, sterilization may be required under the applicable
GMP standard. Similar standards will apply for lipid or fatty acid compositions to be applied
in cosmetic or pharmaceutical compositions. All these measures for formulating oil, lipid or
fatty acid compositions as products are comprised by the aforementioned manufacture.
The term " oil" refers to a fatty acid mixture comprising unsaturated and/or saturated fatty
acids which are esterified to triglycerides. Preferably, the triglycerides in the oil of the
invention comprise PUFA or LCPUFA as referred to above. The amount of esterified PUFA
and/or LCPUFA is, preferably, approximately 30%, a content of 50% is more preferred, a
content of 60%, 70%, 80% or more is even more preferred. The oil may further comprise
free fatty acids, preferably, the PUFA and LCPUFA referred to above. For the analysis, the
fatty acid content can be, e.g., determined by GC analysis after converting the fatty acids
into the methyl esters by transesterification. The content of the various fatty acids in the oil
or fat can vary, in particular depending on the source. The oil, however, shall have a non-
naturally occurring composition with respect to the PUFA and/or LCPUFA composition and
content. It will be understood that such a unique oil composition and the unique
esterification pattern of PUFA and LCPUFA in the triglycerides of the oil shall only be
obtainable by applying the methods of the present invention specified above. Moreover, the
oil of the invention may comprise other molecular species as well. Specifically, it may
comprise minor impurities of the polynucleotide or vector of the invention. Such impurities,
however, can be detected only by highly sensitive techniques such as PCR.
The contents of all references cited throughout this application are herewith incorporated by
reference in general and with respect to their specific disclosure content referred to above.
FIGURES
Figure 1 shows a schematical figure of the different enzymatic activities leading to the
production of ARA, EPA and DHA.
Figure 2 shows a yeast expression experiment with feeding of 22:5n-3 in the prescence (A)
and absence (B) of d4Des(Eh)
Figure 3 shows a yeast expression experiment with feeding of 20:3n-3 in the prescence (A)
and absence (B) of d8Des(Eh)
Figure 4 shows a yeast expression experiment with feeding of 18:3n-3 in the prescence (A)
and absence (B) of d9Elo(Eh)
Figure 5 shows a yeast expression experiment with feeding of 18:3n-6 (GLA) and 18:4n-3
(SDA) in the prescence (A) and absence (B) of d5Elo(Eh)
Figure 6 shows a yeast expression experiment with feeding of 20:4n-6 (ARA) and 20:5n-3
(EPA) in the prescence (A) and absence (B) of d5Elo(Eh)
Figure 7 shows the expression of d9Elo(Eh) in seeds of two Arabidopsis events. As control
seeds not expression d9Elo(Eh) are shown (WT).
Figure 8 shows the Acyl-CoA analysis of mature Arabidopsis seeds from both events
expressing the d9Elo(Eh) in comparison to seeds not expressing d9Elo(Eh) (CoIO)).
Figure 9 shows the expression of d9Elo(Eh), dδDes(Eh) and d5Des(Eh) in seeds of various
Arabidopsis events.
Figure 10 shows gas chromatographic analysis of mature Arabidopsis seeds transformed
with the construct OstELO5EmD4. Peaks were quantified and listed in the table below. The
products of d5Elo(Ot) and d4Des(Eh) activity are 22:6n-3 (DHA).
Figure 11 is a comparison between two d4-desaturases (Tc and Eh) showing that d4Des(Eh) is
different from known d4-desaturases in producing a high ratio of DHA:DPA.
Figure 12 shows the expression of d5Elo(Eh) in seeds of various Arabidopsis events.
Figure 13 is a comparison between three different d6-desaturases and the substrate specificity
ofd5Des(Eh).
This invention is further illustrated by the following examples which should not be construed
as limiting. The contents of all references, patents and published patent applications cited
throughout this application, as well as the figures, are incorporated herein by reference.
EXAMPLES
Example 1: Organism and culture conditions
Emiliana huxleyi was grown as described in Sciandra et al. (2003) Marine Ecology Progress
Series 261 : 1 11-122 with following conditions:
Growth in 50 ml inconical flasks using K/2 medium (Keller et al. ( 1987) Journal of Phycology
23:633-638). The flasks were placed in a growth chamber at a temperature of 17 ± 0.1 0C
under 14L10D irradiance. Light was provided by fluorescent lamps giving a photon
fluxdensity (400 to 700 nm) of 170 µ mol photon m- 2 s- 1.
Example 2 : Cloning of novel desaturase and elongase sequences
RNA from cells grown as described under Example 1 was extracted using the RNA-
extraction Kit from Qiagen, a RACE-library was generated using the RACE-Kit from
Clontech. From the RACE-library sequences for desaturase and elongases were amplified
with PCR using following primer pairs and PCR conditions.
PCR reaction (50 µ L):
5,00 µ L Template cDNA
5,00 µ L 10x Puffer (Advantage-Polymerase)+ 25ιmM MgCI2
5,00 µ L 2mM dNTP
1,25 µ L je Primer (10 pmol/µ L)
0,50 µ L Advantage-Polymerase
The Advantage polymerase mix from Clontech was used.
Reaction conditions of the PCR:
Annealing: 1 min 550C
Denaturation: 1 min 940C
Elongation: 2 min 720C
Cycles: 35
Primer pairs used in PCR:
The PCR reactions resulted in following polynucleotide sequences:
A list of identified full-length coding sequences is shown in Table 1.
Table 1: List of full-length coding sequences and deduced amino acid sequences
Open reading frames as shown in Table 1 were cloned into the pESC(Leu) vector from
Stratagene according to manufactures reaction conditions. Reactions were transformed into
E. coli DH α and plasmid DNA was isolated. The plasmids pESC-d4Des(Eh), pESC-
d8Des(Eh), pESC-d9Elo(Eh), pESC-dδElo(Eh) were then used for yeast transformation.
Example 3 : Yeast Transformation and Growth Conditions
S. cerevisiae strain INVSC from Invitrogen was transformed with the constructs pESC-
d4Des(Eh), pESC-dδDes(Eh), pESC-d Elo(Eh), pESC-d5Elo(Eh) and pESC using the S. C.
EasyComp Transformation Kit (Invitrogen, Carlsbad, California) with selection on leucine-
deficient medium.
Yeast were grown after transformation in complete medium containing all amino acids and
nucleotides. Then yeast were plated on different medium containing either the complete
medium (SD) or the complete medium lacking leucine (SD-Leu). Only yeast containing
pESC-d4Des(Eh), pESC-dδDes(Eh), pESC-d9Elo(Eh), pESC-d Elo(Eh) or pESC vector
can grow on this medium.
Example 4 : Functional expression of desaturases and elongases in yeast and gas
chromatographic analysis.
Yeast cells containing the respective pESC plasmids as prepared above were incubated 12
h in liquid DOB-U medium at 28 0C, 200 rpm inkubiert and than additional 12 h in induction
medium (DOB-U+2% (w/v) galactose + 2% (w/v) raffinose). To the induction medium 250
µ M of the respecitve fatty acids were added to check for enzyme activity and specificity.
Yeast cells were analyzed as following:
Yeast cells from induction medium were harvested by centrifugation (100 x g, 5 min, 2 O0C)
and washed with 100 mM NaHCCb, pH 8,0, to remove residual fatty acids. From the yeast
pellet a total extract of fatty acid methylesters (FAME) was generated by adding 2 ml 1 N
methanolic sulfuric acid and 2% (v/v) Dimethoxypropan for 1 h at 8 O0C. FAME were
extracted two times with Petrolether (PE). Not derivased fatty acids were removed by
washing with 2 ml 100 mM NaHCO3, pH 8,0 and 2 ml Aqua dest. The PE-phases were
dried with Na2SO4 and eluted in 100 µl PE. The samples were then separated with a DB-23-
column (30 m, 0,25 mm, 0,25 µm, Agilent) in a Hewlett-Packard 6850-machine with FID
using following conditions: oven temperature 5 O0C to 25O0C with a rate of 5°C/min and
finally 10 min at 25O0C.
The identification of the fatty acids was done using the retention times of known fatty acid
standards (Sigma). The method is described e.g. in Napier and Michaelson, 2001 ,Lipids.
36(8):761-766; Sayanova et al., 2001 , Journal of Experimental Botany. 52(360):1 581 -1585,
Sperling et al., 2001 , Arch. Biochem. Biophys. 388(2):293-298 und Michaelson et al., 1998,
FEBS Letters. 439(3):215-218.
Example 5 : Functional characterization of d4Des(Eh).
As described above d4Des(Eh) was functionally characterized in yeast. The result of the
analysis is shown in Figure 2 . Yeast transformed with pESC-d4Des(Eh) was compared to
yeast transformed with pESC (control) while feeding the yeast cells with the fatty acid DPA
22:5n-3. Based on this comparison pESC-d4Des(Eh) exhibits d4-desaturase activity as in
the control no 22:6 is observed. Therefore d4Des(Eh) is a functional d4-desaturase.
Example 6: Functional characterization of d8Des(Eh).
As described above d8Des(Eh) was functionally characterized in yeast. The result of the
analysis is shown in Figure 3 . Yeast transformed with pESC-d δDes(Eh) was compared to
yeast transformed with pESC (control) while feeding the fatty acid 20:3n-3. Based on this
comparison a new fatty acid was formed compared to the control, which is 20:4n-3. The
formation of this fatty acid proves that d8Des(Eh) was functionally expressed and has d8-
desaturase activity. The conversion rate of 20:3n-3 to 20:4n-3 was 5%.
Example 7: Functional characterization of d9Elo(Eh).
As described above d9Elo(Eh) was functionally characterized in yeast. The result of the
analysis is shown in Figure 4 . Yeast transformed with pESC-d9Elo(Eh) was compared to
yeast transformed with pESC (control) while feeding the fatty acids 18:3n-3 (ALA) or 18:2
(LA). Based on this comparison a new fatty acid was formed compared to the control, which
is 20:3n-3 or 20:2n-6, respectively. The formation of these fatty acids proves that d9Elo(Eh)
was functionally expressed and has d9-elongase activity. The conversion rate of 18:3n-3 to
20:3n-3 was 17%, the conversion rate of 18:2n-6 to 20:2n-6 was 49%.
Example 8: Functional characterization of d5Elo(Eh).
As described above d5Elo(Eh) was functionally characterized in yeast. The result of the
analysis is shown in Figures 5 and 6 . Yeast transformed with pESC-d5Elo(Eh) was
compared to yeast transformed with pESC (control) while feeding the fatty acids 18:3n-6
(GLA), 18:4 (SDA) or 20:4n-6 (ARA), 20:5n-3 (EPA), respectively. Based on this
comparison new fatty acids formation was observed when compared to the control, which is
20:3n-6 or 20:4n-3 when fed GLA or SDA and 22:4n-6 or 22:5n-3 when fed ARA or EPA,
respectively. The formation of these fatty acids proves that d5Elo(Eh) was functionally
expressed and has d5-elongase activity. The conversion rate of GLA was 13%, the
conversion rate of 18:4n-3 was 30%, the conversion rate of ARA was 38% and the
conversion rate of EPA was 30%. Surprisingly the elongase used a wide variety of
substrates of elongation. The specification indicates a multifunctional elongase activity with
higher specificities for omega3 fatty acids.
Example 9 : Expression of novel elongases from Emiliana huxleyi in plants.
The novel desaturases and elongases were cloned into a plant transformation vector as
described in WO2003/093482, WO2005/083093 or WO2007/093776. Exemplary suitable
combinations of genes are described in Table 2 , 3 and 4 .
Table 2 : Gene combinations for the production of ARA.








Transgenic rapeseed lines were generated as described in Deblaere et al, 1984, Nucl.
Acids. Res. 13, 4777-4788 and seeds of transgenic rapeseed plants are analyzed as
described in Qiu et al. 2001, J. Biol. Chem. 276, 31561-31566.
Transgenic Arabidopsis plants were generated as described in Bechtholdt et al. 1993 CR.
Acad. Sci. Ser. Ill ScLVie., 316, 1194-1 199. Seeds of transgenic Arabidopsis plants
expressing d9Elo(Eh) by using the seed-specific promoter Glycinin from soybean (Lelievre
et al. (1992) Plant Physiol 98:387-391) were analyzed by gas chromatography (Figure 7).
Compared to non-transgenic control plants (WT) there are changes in the fatty acid profile,
proving that d9Elo(Eh) was functionally expression in seeds. The major shifts in the fatty
acid profile is directed to a IOfold increase in the fatty acid 20:2n-6 and 20:3n-3 (Figure 7).
Therefore d9Elo(Eh) exhibits a ∆9-elongase activity, which is consistent with the yeast
characterization. Further, the levels of 18:2 and ALA in the transgenic events expressing
d9Elo(Eh) are lowered compared to WT, as these fatty acids are direct substrates for the
d9Elo(Eh). Further, the endogenous elongation system in the plant is unchanged as levels
of 20:1 and 22:1 are similar between transgenic plants expression d9Elo(Eh) and WT
control. This indicates that the expression of d9Elo(Eh) does not disturb endogenous
elongation process, but delivers additional activity.
To further prove the activity of d9Elo(Eh) expressed in seeds of Arabidopsis thaliana
AcylCoA-measurements were done. Substrates and products of the d9Elo(Eh) elongation
reaction are AcylCoA-esters, which are then further incorporated into triacylglycerides (oil).
The analysis of the acylCoA-pool reveals the formation and flux of the elongation reaction.
Figure 8 summarizes the AcylCoA measurements for Arabidopsis event expressing
d9Elo(Eh) in comparison to controls not expressing d9Elo(Eh) (CoIO). The change in the
chromatogram is indicated by a star. At this position a massive amount of 20:2n-6 is
detected, which is much lower in the control. The conditions for separation of the fatty acid
CoA-esters does not allow the detection of 20:3n-3 as this CoA ester is not separated from
18:3CoA.
The massive occurrence of 20:2n-6-CoA proves the expression of d9Elo(Eh) as this is the
direct product of its enzymatic activity.
Further, transgenic Arabidopsis lines have been generated to validate the activity of d8Des(Eh)
and d5Des(Eh). Vector AP2 has been constructed according to standard molecular biology
steps as described in WO2003/093482, WO2005/083093, WO2007/093776 or WO2009/016202
and transformed into Arabidopsis thaliana as described above. Analysis of transgenic seeds is
shown in Fig. 9. The products of d9Elo(Eh) are 20:2 and 20:3n-3.
Further, transgenic Arabidopsis lines have been generated to validate the activity of d4Des(Eh).
Construct OstELO5EmD4 was transformed into Arabidopsis as described above and seeds of a
number of individual lines have been analyzed by gas chromatography (Fig. 10). The activity of
d4Des(Eh) is demonstrated by the formation of DHA 22:6 (last column). All lines show the
production of DHA with levels of up to 4.7%. Of special interest is the ratio of DHA to DPA.
Surprisingly the ratio of d4Des(Eh) is much higher than in d4-desaturases known in the art. A
comparison against the d4-desaturase from Thraustochytrium ssp. of WO2002/026946 is shown
in Fig. 11. The enzyme from Thraustochytrium ssp. showed so far highest levels of DHA
(WO2005/083093), but with an unfavorable ratio of DPA to DHA. A high ratio of DHA:DPA is for
the commercial use of such oils of importance.
Further, transgenic Arabidopsis lines have been generated to validate the activity of d5Elo(Eh).
Construct EmELO5TcD4 was transformed into Arabidopsis as described above and seeds of a
number of individual lines have been analyzed by gas chromatography (Fig. 12). The activity of
d5Elo(Eh) is demonstrated by the formation of DPA 22:5 and DHA 22:6. Most lines show the
production of these two fatty acids, proofing that d5Elo(Em) is functionally expressed in the
seeds.
Further, transgenic Arabidopsis lines have been generated to validate the activity and substrate
specificity of d5Des(Eh). For this purpose two ∆6-desaturases were selected based on their
different substrate specificity. The borage∆ Θ is expected to use phosphatidylcholin-18:2 as
substrate (WO96/21022), whereas the Ostreococcus ∆6 (Ostr∆ Θ) uses Acyl-CoA ester
(WO2005/012316). In combination with the d6-elongase from Physcomitrella patens
(WO2001/059128) both d6-desaturases produce DGLA or 20:4n-3, respectively. The ratio of
ARA to EPA is for the borage∆β 2.9, for the Ostr∆β 2.3. It is noted that the use of Ostr∆ Θ results
in 3-4 times higher levels of products compared to the borage∆Θ. The further combination of the
d5Des(Eh) resulted in the production of ARA and EPA, demonstrating the functionality of the
d5Des(Eh). The conversion of d5Des(Eh) of DGLA to ARA is 29% (borage∆ Θ) or 47% (Ostr∆ Θ) .
For 20:4n-3 to EPA it is 33% (borage∆ Θ) or 2Θ% (Ostr∆ Θ) .
Based on these results it is concluded that for Acyl-CoA substrates d5Des(Eh) is specific for the
omegaθ fatty acid DGLA. This is a novel substrate specificity not observed in the state of the art
d5-desaturases.
Reference List
Arondel,V., Lemieux,B., Hwang, I., Gibson, S., Good man, H.M., and Somerville,C.R. (1992).
Map-based cloning of a gene controlling omega-3 fatty acid desaturation in Arabidopsis.
Science 258, 1353-1355.
Broadwater,J.A., Whittle, E., and Shanklin,J. (2002). Desaturation and hydroxylation.
Residues 148 and 324 of Arabidopsis FAD2, in addition to substrate chain length, exert a
major influence in partitioning of catalytic specificity. J. Biol. Chem. 277, 15613-15620.
Broun, P., Shanklin,J., Whittle,E., and Somerville,C. (1998b). Catalytic plasticity of fatty acid
modification enzymes underlying chemical diversity of plant lipids. Science 282, 1315-1317.
Calvo,A.M., Gardner,H.W., and Kelle N.P. (2001). Genetic connection between fatty acid
metabolism and sporulation in Aspergillus nidulans. J. Biol. Chem. 276, 25766-25774.
Knutzon,D.S., Thurmond.J.M., Huang.Y.S., Chaudhary,S., Bobik,E.G., Jr., Chan, G.M.,
Kirchne S.J., and Mukerji,P. (1998). Identification of Delta -dehydratase from Mortierella
alpina by heterologous expression in Bakers' yeast and canola. J . Biol. Chem. 273, 29360-
29366.
Mantle, P.G . and Nisbet,L.J. (1976). Differentiation of Claviceps purpurea in axenic culture.
J. Gen. Microbiol. 93, 321-334.
Mey,G., Oeser,B., Lebrun,M.H., and Tudzynski,P. (2002). The biotrophic, non-
appressorium-forming grass pathogen Claviceps purpurea needs a Fus3/Pmk1 homologous
mitogen-activated protein kinase for colonization of rye ovarian tissue. MoI. Plant Microbe
Interact. 15, 303-312.
Okuley,J., Lightner.J., Feldmann,K., Yadav,N., Lark, E., and Browse,J. (1994). Arabidopsis
FAD2 gene encodes the enzyme that is essential for polyunsaturated lipid synthesis. Plant
Cell 6 , 147-158.
Qi, B., Fraser,T., Mugford,S., Dobson,G., Sayanova,O., Butle J., Napie J.A., Stobart,A.K.,
and Lazarus, C.M. (2004). Production of very long chain polyunsaturated omega-3 and
omega-6 fatty acids in plants. Nat. Biotechnol. 22, 739-745.
Qiu,X., Hong, H., and McKenzie, SL. (2001) Identification of a Delta 4 fatty acid desaturase
from Thraustochytrium sp. involved in the biosynthesis of docosahexanoic acid by
heterologous expression in Saccharomyces cerevisiae and Brassica juncea. J Biol Chem
276, 31561-6.
Shanklin,J. and Cahoon,E.B. (1998). DESATURATION AND RELATED MODIFICATIONS
OF FATTY ACIDS1 . Annu. Rev. Plant Physiol Plant MoI. Biol. 49, 6 11-641 .
Tudzynski,P., Correia,T., and Keller,U. (2001). Biotechnology and genetics of ergot
alkaloids. Appl. Microbiol. Biotechnol. 57, 593-605.
All references cited in this specification are herewith incorporated by reference with respect
to their entire disclosure content and the disclosure content specifically mentioned in this
specification.
CLAIMS
1. A polynucleotide comprising a nucleic acid sequence elected from the group
consisting of:
a) a nucleic acid sequence having a nucleotide sequence as shown in SEQ ID
NOs: 1, 3 , 5 , 7 or 9 ;
b) a nucleic acid sequence encoding a polypeptide having an amino acid sequence
as shown in SEQ ID NOs: 2 , 4 , 6 , 8 or 10;
c) a nucleic acid sequence being at least 70% identical to the nucleic acid
sequence of a) or b), wherein said nucleic acid sequence encodes a polypeptide
having desaturase or elongase activity;
d) a nucleic acid sequence encoding a polypeptide having desaturase or elongase
activity and having an amino acid sequence which is at least 82% identical to the
amino acid sequence of any one of a) to c); and
e) a nucleic acid sequence which is capable of hybridizing under stringent
conditions to any one of a) to d), wherein said nucleic acid sequence encodes a
polypeptide having desaturase or elongase activity.
2 . The polynucleotide of claim 1, wherein said polynucleotide further comprises an
expression control sequence operatively linked to the said nucleic acid sequence.
3 . The polynucleotide of claim 1 or 2 , wherein said polynucleotide further comprises a
terminator sequence operatively linked to the nucleic acid sequence.
4 . A vector comprising the polynucleotide of any one of claims 1 to 3 .
5 . A host cell comprising the polynucleotide of any one of claims 1 to 3 or the vector of
claim 4 .
6 . A method for the manufacture of a polypeptide encoded by a polynucleotide of any
one of claims 1 to 3 comprising
a) cultivating the host cell of claim 5 under conditions which allow for the production
of the said polypeptide; and
b) obtaining the polypeptide from the host cell of step a).
7 . A polypeptide encoded by the polynucleotide of any one of claims 1 to 3 or which is
obtainable by the method of claim 6 .
8 . A non-human transgenic organism comprising the polynucleotide of any one of
claims 1 to 3 or the vector of claim 4
9 . The non-human transgenic organism of claim 8 , which is a plant, plant part, or plant
seed.
10. A method for the manufacture of polyunsaturated fatty acids comprising:
a) cultivating the host cell of claim 5 under conditions which allow for the production
of polyunsaturated fatty acids in said host cell; and
b) obtaining said polyunsaturated fatty acids from the said host cell.
11. A method for the manufacture of polyunsaturated fatty acids comprising:
a) cultivating the non-human transgenic organism of claim 8 or 9 under conditions
which allow for the production of polyunsaturated fatty acids in said non-human
transgenic organism; and
b) obtaining said polyunsaturated fatty acids from the said non-human transgenic
organism.
12. The method of claim 10 or 11, wherein said poly-unsaturated fatty acid is arachidonic
acid (ARA), eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA).
13. A method for the manufacture of an oil, lipid or fatty acid composition comprising the
steps of the method of any one of claims 10 to 12 and the further step of formulating
the polyunsaturated fatty acid as oil, lipid or fatty acid composition.
14. The method of claim 13, wherein said oil, lipid or fatty acid composition is to be used
for feed, foodstuffs, cosmetics or medicaments.
15. An Antibody or a fragment thereof which specifically recognizes the polypeptide of
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